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RÉSUMÉ 
Implication de Beta-arrestin 1 et Beta-arrestin 2 dans  l'entrée capacitative de calcium 
Par 
Cynthia Sharmeen, Département de pharmacologie 
Mémoire présenté à la Faculté de médecine et des sciences de la santé en vue de l’obtention 
du diplôme de maitre ès sciences (M.Sc.) en pharmacologie, Faculté de médecine et des 
sciences de la santé, Université de Sherbrooke, Sherbrooke, Québec, Canada, J1H 5N4 
 
La variation de la [Ca2+] intracellulaire participe à nombreux de processus biologiques. Les 
cellules eucaryotes expriment à la membrane plasmique une variété de canaux par 
lesquelles le calcium peut entrer. Dans les cellules non excitables, deux mécanismes 
principaux permettent l'entrée calcique; l'entrée capacitative de Ca2+ via Orai1 (SOCE) et 
l'entrée calcique activé par un récepteur (ROCE). Plusieurs protéines clés sont impliquées 
dans la régulation de ces voies d'entrée calcique, ainsi que dans l'homéostasie calcique. 
TRPC6 est un canal calcique impliquée dans l'entrée calcique dans les cellules à la suite 
d’une stimulation d’un récepteur hormonal. TRPC6 transloque à la membrane cellulaire et 
il y demeure jusqu'à ce que le stimulus soit retiré.  Les mécanismes qui régulent le trafic et 
l'activation de TRPC6 sont cependant encore peu connus. Des découvertes récentes ont 
démontré qu'il y a un rôle potentiel de Rho kinase dans l'activité de TRPC6. Rho kinase est 
activée par la petite protéine G RhoA qui peut être activée par les protéines G 
hétérotrimériques Gα12 et Gα13. En plus de  Gα12 et Gα13,  les protéines de 
désensibilisation des GPCR β -arrestin 1 et / ou β-arrestin 2 peuvent aussi activer RhoA. Le 
but de notre étude est d'examiner la participation des protéines Gα12/13 et  β-arrestin 1/ β-
arrestin 2 dans l'activation de TRPC6 et de la protéine Orai1. Nous avons utilisé des ARN 
interférant (siRNA) spécifiques pour induire une réduction de l'expressionde Gα12/13 ou β-
arrestin 1/β-arrestin 2. La conséquence sur l’entrée de Ca2+ dans les cellules a été ensuite 
déterminée par imagerie calcique en temps réel suite à une stimulation par la vasopressine 
(AVP), thapsigargin ou carbachol. Nous avons donc identifié que dans des cellules A7r5, 
une lignée cellulaire de musculaires lisses vasculaires où le canal TRPC6 exprimé de 
manière endogène, la diminution de l’expression des protéines Gα12 ou Gα13 ne semble 
pas modifier l’entrée Ca2+ induit par l’AVP par rapport aux cellules témoins. D'autre part, la 
diminution de l’expression β-arrestin 1 ou β-arrestin 2 dans des cellules HEK 293 ainsi que 
des cellules HEK 293 exprimant de façon stable TRPC6 (cellules T6.11) ont augmenté 
l’entrée de Ca2+ induite par thapsigargin, un activateur pharmacologique de SOCE. Des 
études de co-immunoprécipitation démontrent une interaction entre la β-arrestin 1 et 
STIM1, alors qu'aucune interaction n'a été observée entre les β-arrestin 1 et Orai1. Nous 
avons de plus montré à l'aide d'analyse en microscopie confocale que la diminution de 
l’expression β-arrestin 1 ou β-arrestin 2 n’influence pas la quantité d’Orai1 à la périphérie 
cellulaire. Cependant, des résultats préliminaires indiquent que la diminution de 
l’expression β-arrestin 1 ou β-arrestin 2 augmente la quantité de STIM1-YFP dans l'espace 
intracellulaire et diminue sa quantité à la périphérie cellulaire. En conclusion, nous avons 
montré que les β-arrestin 1 ou β-arrestin 2 sont impliquées dans l'entrée capacitative de 
Ca2+ (SOCE) et  contrôlent la quantité de STIM1 dans le réticulum endoplasmique. 
Mots clés: TRPC6, ROCE, SOCE, entrée calcique, signalisation cellulaire, imagerie 
calcique. 
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SUMMARY 
Involvement of Beta-arrestin 1 and Beta-arrestin 2 in store operated calcium entry 
By 
 
Cynthia Sharmeen, Department of pharmacology 
 
Thesis presented to the Faculty of medicine and health sciences to obtain the degree Master 
of Science (M.Sc.) in pharmacology, Faculty of medicine and health sciences, Université 
de Sherbrooke, Sherbrooke, Quebec, Canada, J1H 5N4 
 
In an organism, intracellular [Ca2+] takes part in many biological processes. Eukaryotic 
cells express a variety of channels in the plasma membrane through which calcium can 
enter. In non-excitable cells, two main mechanisms allow calcium entry; the store-operated 
calcium entry via Orai1 (SOCE) and receptor-operated calcium entry (ROCE). Several key 
proteins are involved in the regulation of these calcium entry pathways as well as in 
calcium homeostasis. TRPC6 is a calcium channel implied in calcium entrance into the 
cells following hormonal stimulation and translocates to the plasma membrane. TRPC6 
channel appear to the plasma membrane until the stimulus is present. Although, the 
mechanisms that regulate the trafficking and activation of TRPC6 are still little known. 
Recent findings have demonstrated that there is a potential role of Rho kinase in activity of 
TRPC6. Rho kinase is activated by the small G protein RhoA that itself can be activated by 
the heterotrimeric G proteins Gα12 and Gα13. In addition to Gα12 and Gα13 proteins, 
cytosolic GPCR desensitizing proteins β-arrestin 1 and/or β-arrestin 2 could also activate 
RhoA. The purpose of our study is to investigate the involvement of the proteins Gα12/13 
and β-arrestin 1/β-arrestin 2 in the activation of TRPC6 and Orai1 protein. We used siRNA 
specific to Gα12/13 or β-arrestin 1/β-arrestin 2 to knockdown their endogenous expression. 
Then, calcium imaging in real time was performed in order to see the quantity of calcium 
entered into the cell following stimulation by vasopressin (AVP), thapsigargin, or 
carbachol. We hence identified that in A7r5 cell, vascular smooth muscle cell where 
TRPC6 channel expressed endogenously; reduced expression of Gα12 or Gα13 proteins 
does not seem to modify the AVP-induced Ca2+ entry compared to control cells. On the 
other hand, calcium imaging experiment in knocked down β-arrestin 1 or β-arrestin 2 in 
HEK 293 cells as well as HEK 293 cells stably transfected with TRPC6 (T6.11 cells) 
resulted in an increased thapsigargin-induced calcium entry. The co-immunoprecipitation 
studies demonstrate an interaction between β-arrestin 1 and STIM1, a calcium sensor in 
SOCE influx, while no interaction was observed between β-arrestin 1 and Orai1.We 
moreover showed by confocal microscopy that reduced expression of β-arrestin 1/ β-
arrestin 2 does not influence the quantity of Orai1 at the cell periphery. Preliminary results 
showed that reduced expression of β-arrestin 1 or β-arrestin 2 increases the quantity of 
STIM1-YFP in the intracellular space and less it’s in peri-membrane space. In conclusion, 
we showed that β-arrestin 1 or β-arrestin 2 are involved in the store-operated calcium entry 
(SOCE) and control the quantity of STIM1 in the endoplasmic reticulum.  
 
Key words: TRPC6, ROCE, SOCE, calcium entry, cell signaling, calcium imaging. 
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INTRODUCTION 
1. Calcium:  an important second messenger 
 
It is widely known that calcium is an important second messenger carrying information at 
various time intervals to all processes important to cell life; ranging from birth through the 
development, function, and death of cells, tissues, through actions like muscle contraction, 
exocytosis, cell metabolism, transcription and proliferation (BERRIDGE MJ, 2000). The 
information that calcium carries is through binding to proteins followed by specific 
conformational changes and subsequently reaching the target. There are also membrane 
bound proteins that transport calcium across boundaries (CARAFOLI E, 2001). All the 
complex cellular processes are triggered through changes in intracellular calcium 
concentrations which are determined by the balance of activation and inactivation events 
(BERRIDGE MJ, 2003). Activation event is triggered by an increase in the intracellular 
calcium concentration. The high calcium concentration in the cell can be achieved from two 
different sources; one of which is the endoplasmic reticulum (ER), which is as an 
intracellular calcium reservoir. The second is the extracellular medium. The intracellular 
Ca2+ concentration ([Ca2+]i) in a resting cell is usually between 50 and 100 nM. Following 
stimulation by a hormone or desensitization, this concentration increases rapidly. The 
calcium concentrations of ER and the extracellular medium are approximately 1 to 2 mM, 
which is 10 000 to 20 000 times higher than that the concentration in the cytoplasm 
(CLAPHAM DE , 2007). So there is a large chemical gradient favouring calcium entry into 
the cytoplasm. On the other hand, inactivation event implicate in the removal of cytosolic 
Ca2+. The presence of pumps and exchangers as well as buffer actions altogether aid in the 
process of removal of calcium ions. Hence, there is always a physiological balancing of 
intracellular [Ca2+]i .  
 
The plasma membrane (PM) contains several types of channels that permit the penetration 
of Ca2+ down its electrochemical gradient and maintain regulatory mechanisms of [Ca2+]i. 
These channels can be divided into three major groups: (1) channels in which the gating 
depends on “voltage” namely: VOCs, voltage-operated Ca2+ channels (Cav family), a 
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characteristic of “excitable cells,” that require depolarization of the PM for activation. 
(HESS P, 1984); (2) channels in which the gating depends on “ligand binding” (ROCs, 
receptor-operated Ca2+ channels):  that generally involve by secondary messenger- linked  
G protein-coupled receptor (GPCR) activation; and (3) channels that are activated by the 
depletion of ER Ca2+ stores (SOCs, store-operated Ca2+ channels) through a mechanism 
known as capacitative calcium entry (CCE) (PUTNEY JW, 1986). It is important to 
mention that the, types of channels present (and/or predominant) vary with the cell type 
which could be either excitable or non-excitable (CARAFOLI E, 2001).  
2. Calcium homeostasis  
 
Too high concentration of [Ca2+]i into the cell  can cause cell death through apoptosis 
(ORRENIUS S, 2003). These phenomenon urges in depth study on the level of intracellular 
[Ca2+]i in the cell as well as their regulation via different channels.  
 
Calcium ions enter into the cells via SOC or ROC channels. They are stored in intracellular 
organelles; including Mitochondria and the ER. These organelles constantly accumulate 
Ca2+ ions and release them during certain cellular events. When there is an overloaded 
cytosolic Ca2+ upon various stimuli, Ca2+ accumulation takes place in mitochondria. 
Excessive accumulation of Ca2+ in mitochondria is a major cause of the opening of the 
permeability transition pore (PTP) in mitochondria (VALENTINA G, 2013).  Activation of 
PTP located at the interphase of the inner and outer mitochondrial membranes  causes the 
release of mitochondrial pro-apoptotic factors such as cytochrome C (CytC) and apoptosis 
inducing factor (AIF) in the cytoplasm, which in turn activate caspases (GALLUZZI L, 
2012). In addition to mitochondria, ER is the major Ca2+ storage and Ca2+ depletion from 
ER can trigger apoptosis via the induction of SOCE (Store operated calcium entry) through 
STIM1-Orai1 pathway (MAGI S, 2016). Thus, any disturbances of ER Ca2+ homeostasis 
can lead to the induction of apoptosis.  
 
On the other hand, an increase in cytosolic free Ca2+ due to the activation of calcium 
sensing receptor  (CaSR) sets into motion a complex series of downstream signaling 
cascades to cause cell contraction, migration and proliferation. It is reported that, when 
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mRNA and protein expression of CaSR is upregulated, extracellular Ca2+ induced increase 
in cytosolic Ca2+ is enhanced (WAN J, 2013) (YAMAMURA A, 2012). It is also 
mentioned that the upregulation of TRPC6 (ROC) resulted in enhanced SOCE (YU Y1, 
2004) (YU Y2, 2003) in pulmonary arterial smooth muscle cell (PASMC) from idiopathic 
pulmonary arterial hypertension (IPAH) patients in comparison to normal control PASMC. 
These findings indicate that, CaSR and TRPC6 functionally interact with each other to 
regulate cytosolic Ca2+ concentration in PASMC (HAIYANG T, 2016).  
2.1 Balancing excessive intracellular Ca2+ concentration 
 
To avoid excessive accumulation of [Ca2+]i, which would be harmful for the cell, the 
exchanges of Ca2+ between the intracellular and extracellular medium or the ER occur 
through key proteins as plasma membrane calcium ATPase (PMCA), Na+/ Ca2+ exchanger 
(NCX) and sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) (fig.1). The 
two main mechanisms that the cell uses to export Ca2+ to the extracellular medium are 
PMCA pump and the NCX. The PMCA pumps cytosolic Ca2+ into the extracellular 
medium by the hydrolysis of ATP. The PMCA pumps were discovered in red blood cell 
membranes by Schatzmann (SCHATZMANN HJ, 1966). NCX exchanger functions as an 
electrogenic gradient. The NCX have a low affinity for Ca2+ but they can lower quickly 
intracellular Ca2+ concentration in exchange for 3 Na+ ions into the cell (BERRIDGE MJ, 
2012). NCX, an anti-porter membrane protein utilises the Na+ gradient provided by the Na, 
K-ATPase (NKA), to remove Ca2+ from cells (fig.1).  
 
In mammals, SERCA is the primary transporter facilitating Ca2+ translocation into the 
sarcoplasmic reticulum (SR) (BERS DM, 1997). SERCA pumps the Ca2+ from the cytosol 
to the ER at the expense of ATP hydrolysis (POZZAN T, 1994). Two Ca2+ ions from the 
cytoplasm bind to SERCA pump. SERCA is then subsequently phosphorylated by ATP at 
Asp351. This high energy, phosphorylated form of SERCA translocates the Ca2+ ions into 
the SR lumen (Fig.1). The rate at which SERCA moves Ca2+ across the SR membrane can 
be controlled by the regulatory protein phospholamban (PLB/PLN). A decrease in the ER 
Ca2+ concentration resulting from SERCA pump inhibition is considered as a major cellular 
stress signal (ZHANG C, 2016). Thapsigargin (Tg) is a sesquiterpene lactone that can 
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induce calcium release and is by far the most widely used and efficient irreversible inhibitor 
of SERCA pump (WOOTTON LL, 2006). At low concentrations, Tg does not inhibit ATP-
dependent Ca2+ pumps such as PMCA pumps. However, Tg is selective for different 
isoforms of SERCA. Indeed, the action of Tg is 60 times more potent on SERCA1 than on 
SERCA3 (WOOTTON LL, 2006) . 
 
 
Figure 1. Calcium homeostasis in smooth muscle 
The two families of Ca2+ transporter Ca-ATPase (PMCA) and Na/Ca exchanger (NCX) 
present in the plasma membrane of smooth muscle cells to efflux calcium. NCX is spatially 
coupled to the α2 isoform of the Na, K-ATPase (NKA α2) to directly regulate calcium 
transport. The PMCA is regulated by calmodulin (CaM). NKA α1 is a sodium-potassium 
antiporter. 2K+ enters into the cell in exchange for 3Na+ through NKA α1. NCX co-
localised within caveolae and cholesterol-rich membrane domains with NKA α2 isoforms; 
PMCA with associated calmodulin (CaM) and NKAα1 isoforms; and SERCA with 
associated phospholamban (PLN) complexes. Taken from (FLOYD R, 2007) 
3. Calcium mobilisation 
 
Extracellular stimuli such as electrical, hormonal, or mechanical stimulation can produce 
calcium signals in various cell types. In eukaryotic cells, these stimulations cause calcium 
mobilization that can take place in two separate locations (Fig. 2): (1) Entry of calcium ion 
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across the PM or (2) its release from intracellular stores such as golgi, the endoplasmic and 
sarcoplasmic reticulum. 
 
 
Figure 2. Calcium signalisation in non-excitable cell 
Following stimulation of a GqPCR or RTK, phospholipase C β / γ is activated which allows 
hydrolysis of PIP2 into DAG and IP3. IP3 causes the release of Ca
2+ from reserved ER by 
binding to its receptor channel IP3R. This release is counterbalanced by the action of 
SERCA pump. STIM1, the calcium concentration sensor of ER, activates ORAI1 channels 
when the ER reservoir is empty. It is believed that DAG can activate certain TRPC 
channels by PKC-independent mechanisms. Activation of these channels (TRPC6 and 
Orai1) allows calcium influx from the extracellular medium, and hence sustains signaling. 
 
The calcium release is triggered by binding of a wide variety hormones, neurotransmitters 
and secretagogues to their target receptors located at the plasma membrane. For example, in 
non-excitable cells, calcium release is induced following a stimulation of a G protein 
receptor (GPCR) or a receptor tyrosine kinase (RTK) that activate different types of 
phospholipase C (PLC), either β or γ. The PLC hydrolyze lipid precursor 
phosphatidylinositol-4, 5 bisphosphate (PIP2) into diacylglycerol (DAG) and inositol 1, 4, 
5-triphosphate (IP3) (Figure 2). The PIP2 breakdown is marked by Ca
2+ influx into the cell 
(PUTNEY JW, 2012). The most widely expressed intracellular Ca2+ channel, IP3 receptor 
(IP3R), releases Ca
2+ from intracellular stores in response to binding of IP3 and Ca
2+ 
(FOSKETT JK, 2007) (TAYLOR CW, 2010). IP3R plays an important role in regulating 
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intracellular [Ca2+]i levels in resting cells (PATTERSON RL, 2004), and the ER remains 
the major IP3-sensitive Ca
2+ storage (IINO M, 1987). It is believed that DAG remains at the 
PM and activates protein kinase C (PKC) which can phosphorylate different substrates 
(LARGE WA, 2009).  IP3Rs are believed to interact with many protein including a direct 
interaction between IP3Rs and TRPC (transient receptor potential canonical) channels is 
proposed to induce the opening of the TRPC channel (ZHANG Z, 2001) .  
 
The next location in calcium mobilization is the calcium entry into the cell through several 
channels present on plasma membrane. Eukaryotic cells express a variety of calcium 
permeable channel at the plasma membrane, which can be classified into VOCs (L- and T-
type calcium channels) and voltage independent calcium channels (SOCs, ROCs) 
(GUIBERT C, 2008). Voltage dependent calcium entry through VOC channels is mostly 
found in excitable cells (nerve and muscle cells) whereas in non-excitable cells, the main 
mechanisms allowing calcium to enter the cells are SOCE and receptor-operated calcium 
entry (ROCE). ROCs are believed to be generated through the breakdown of PIP2 by PLC 
upon receptor stimulation.  
 
Our major interest in this research project is to study the entrance of Ca2+ in non-excitable 
cells through SOC and/ ROC channel.  
 
4. Voltage Independent Calcium Entry (VICC)  
 
4.1 Store operated calcium entry (SOCE) 
 
Before the term SOCE was invented, Putney proposed the concept of capacitative Ca2+ 
entry (CCE) (PUTNEY JR., 1986). It was believed that Ca2+ enters the cytoplasm from 
outside the cell by traversing the ER (the “capacitor”). Later the term ‘‘capacitative Ca2+ 
entry’’ (CCE) was renamed to “store-operated calcium entry (SOCE)” which describe the 
phenomenon that a reduction in [Ca2+]i within the lumen of the Ca
2+ storing organelles 
sends a signal to the PM Ca2+ channels. This signalling leads to the activation of SOC 
channels that causes calcium influx across the PM. The coupling phenomenon between ER  
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Ca2+ concentration and the activation of membrane Ca2+ entry channels results in refilling 
the Ca2+ storing organelles, such as ER (CASTEELS R, 1981). The SOC is activated for 
calcium entry only when there is ER calcium store depletion rather than the production of 
IP3 or agonist – receptor occupancy. Many experiments using a variety of drugs such as, Tg 
or cyclopiazonic acid (CPA) causes the depletion of internal Ca2+ stores. Both Tg and CPA 
mobilize Ca2+ within intact cells by inhibiting SERCA pump. Subsequently SOC is 
activated. SOCs are also activated by store depletion via as a consequence of IP3-induced 
Ca2+ release through IP3 receptors in the ER membrane (PAREKH AB, 2005).  
 
Work involved in understanding how ER Ca2+ content is transmitted to the PM to regulate 
SOC channel opening pointed out involvement of a multi-domain, ER resident, Ca2+ 
binding protein named STIM1 (LIOU J , 2005).  
 
4.1.1 STIM protein 
 
STIM, which stand for stromal interaction molecules, acts as a calcium sensor for SOC 
influx. Scientific evidence suggests that STIM and Orai proteins might act as the Ca2+ 
sensor in the intracellular Ca2+ store and the putative calcium release-activated calcium 
channel (CRAC) at the PM, respectively (TAYLOR, 2006). SOC influx is the major 
mechanism for Ca2+ entry in many non-excitable cell types and STIM1 proteins have been 
identified as essential components in SOC influx along with Orai1. Orai1 is a calcium 
selective ion channel encoded by the Orai1 gene in humans (FESKE S, 2006). In addition 
to Orai1, mammalian cells express two additional homologous genes, Orai2 and Orai3. 
Thus STIM1-Orai1 is believed to provide precise local Ca2+ signals that involve multiple 
long-term cellular responses (ORITANI K, 1996). In that way, STIM proteins are 
responsible for the homeostatic control of cellular Ca2+ levels. STIM proteins are localized  
mainly at the ER and to a lesser extent to the PM.  
 
4.1.2 The isoforms: STIM1 and STIM2  
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There are two different iso-forms of STIM protein that come from two distinct genes. 
STIM1 is a protein of 685 amino acids with a molecular weight between 80 and 90 kDa. 
STIM2 is a protein of 746 amino acids with a molecular weight between 105 and 115 kDa. 
STIM1 and STIM2 are highly homologous through 85% of their length, with the notable 
exception of high variability in their amino-terminal and carboxy-terminal segments. STIM 
proteins have a single trans membrane spanning segment with its NH2 terminus oriented 
toward the lumen of the ER (fig. 3). The N-terminus contain Ca2+ binding EF hand domain 
that predicts to lie within the ER lumen (ROOS J, 2005). The adjacent domain of EF-hand 
is the sterile motif (SAM) which is present near the predicted trans-membrane domain. The 
STIM proteins also contain protein–protein interaction domains, notably coiled-coiled 
domains (CC-1 and CC-2) in the cytoplasm near the predicted trans-membrane domain. 
The cytoplasmic C-terminal domain containing the CAD (CRAC activation domain also 
known as SOAR-STIM Orai activating region) that allows STIM proteins to bind and 
activate Orai1. Near the coiled-coil domains at C- terminal, there are a proline-rich 
domaine (P) and polybasic-rich domain (K) (fig. 3A). STIM1 and STIM2 are expressed 
ubiquitously throughout cell types in vertebrates (WILLIAMS RT, 2001). In most tissues 
STIM1 levels are higher than STIM2 levels, but an exception being brain and dendritic 
cells (BANDYOPADHYAY BC, 2011). At the cellular level, STIM1 is predominantly 
localized in the ER and in small proportion to the PM (MANJI SS, 2000). Until today, 
many scientific studies are still under progress to characterize exactly their localization, 
mode of activation and cellular function. 
 
An important difference between the two isoforms of STIM (STIM1 and STIM2) is in their 
EF hand domain structures which bind Ca2+. The dissociation constant at equilibrium (Kd) 
of STIM1 (luminal EF-hand–SAM domain) for Ca2+ is about 200 μM whereas it is about 
400 μM for STIM2.  This Kd difference is presumably due to the differences in EF-hand 
domain structures and their affinity for Ca2+. When the luminal Ca2+ levels falls, Ca2+ 
dissociate from the canonical EF‑hand domain of STIM1 and activate Orai1 (fig. 3) 
(SOBOLOFF J , 2012).  
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The cytoplasmic C-terminal domain of STIM protein contains a small active fragment 
known as the STIM-Orai activating region (SOAR) or CRAC activation domain (CAD). 
SOAR or CAD is the minimal sequence necessary for interaction with and activation of 
Orai channels at the PM (PARK CY, 2009) (YUAN JP, 2009). Since STIM2 protein differs 
subtly from STIM1 in its N-terminal domain, thus there are differences in the rates of 
unfolding of the luminal N-terminal domain. As a result, there are distinct rates of 
activation of STIM1 and STIM2 in response to store depletion (SOBOLOFF J, 2012). The 
interaction and ability to gate Orai1 channels is lower for STIM2. Hence STIM2 responds 
slower than STIM1 and produces low but sustained Ca2+ entry via Orai1 channels (ZHOU 
Y, 2009). Experiment carried out by substitution of a single phenylalanine residue in the 
SOAR1 domain of STIM1 with a leucine residue found in SOAR2 domain of STIM2 
prevents STIM1 to bind and activate both Orai channel, indicating that there is a 
physiologically important distinction between STIM1 and STIM2. STIM1 is a full Orai1-
agonist. However leucine in STIM2 endows it as partial agonist, which is believed to be 
critical for limiting Orai1 activation by STIM2 (WANG X,  2014). 
 
4.1.3 Mechanism of activation of STIM1 and Orai1 
 4.1.3.1 Sensing of low Ca2+ level in ER:  
 
The decrease in [Ca2+]i in the ER is detected by STIMl protein. The EF-hand domain of 
STIM1 could function as Ca2+ sensor in the ER (ROOS J, 2005). Indeed, the luminal N- 
terminus of STIM1 includes two EF-hand motifs 1) a canonical cEF-hand (LIOU J, 2005) 
(ZHANG S, 2005) (13,25) and 2) a hEF-hand that does not bind with Ca2+ (fig. 3A) 
(STATHOPULOS PB, 2008). cEF and hEF hands associate tightly with the adjoining five-
helix SAM domain. With Ca2+ bound to the dual EF-hand and SAM domain (EF-SAM), a 
tight, stable STIM1 EF-SAM configuration is formed. When Ca2+ dissociates, the EF-SAM 
domain unfolds and destabilizes (STATHOPULOS PB, 2008) and leads to rapid 
oligomerization of the EF-SAM regions. This results in the initial response of STIM1 to 
deplete ER Ca2+. Mutations in the EF-hand domain of STIM1 reduce its Ca2+ affinity and 
constitutively activate SOC entry (YEROMIN AV, 2006). The C-terminal cytosolic 
domain of Orai1 takes part in the interactions within a leucine-rich, acidic coiled-coil motif 
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of STIM1 protein as experimentally shown by FRET and patch-clamp studies 
(CALLOWAY N, 2010) (PARK CY, 2009).   
4.1.3.2 Formation of puncta:  
 
In physiologic conditions, STIM1 normally appears to be uniformly distributed on the 
membrane of the ER. On the other hand, Orai1 is a tetra spanning membrane protein 
localized at the PM and appears to be the functional store-operated channel moiety of 
STIM1 (PRAKRIYA M, 2006). Upon store emptying, it was observed that STIM1 
undergoes a profound redistribution within the cell and leads to the appearance of densely 
labeled puncta, an aggregated region of ER STIM proteins (LIOU J, 2005). These regions 
are pre-existing ER-PM junctional domains (WU MM, 2006) within which accumulated 
STIM proteins capture and activate Orai channels. It requires two STIM1 monomers per 
Orai1 subunit to achieve optimal SOC channel activity. Interestingly, the puncta formation 
indicates that STIM1 puncta dissociate and return to an homogenous distribution on the ER 
when calcium enters the cells following SOCE activation (LIOU J , 2005).  
 
4.1.3.3 Activation of SOCE:  
 
These junctional ER-PM coupling domains are the functional sites of store-operated Ca2+ 
entry (MA HT, 2002) (BAUTISTA DM, 2004). Recently, it was found that an ER-resident 
protein, STIM-activating enhancer STIMATE (TMEM110) facilitates and enhances STIM1 
puncta formation at ER-PM junctions (JING J, 2015).  
 
Several scientific studies have shown that Orai1 at the PM interacts with STIMl on the ER, 
causing calcium entry into the cell. However, there are controversies in regard to the 
molecular mechanism and stoichiometry of the coupling process between these two 
proteins. 
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Figure 3. Domain of STIM1 and STIM2 protein and STIM1 in SOC activation 
A) STIM protein domain structures. Comparison of STIM1 and STIM2 domain, including 
signal peptides (SP), a pair of highly conserved cysteines (CC), canonical cEF- and hEF-
hands, SAMs, Asn-linked glycosylation sites (hexagons), TMs, coiled-coil regions (CC1 
and CC2), proline-rich domains (P), and poly basic-rich domains (K). The minimal region 
of STIM1 known to be required for coupling to Orai1 is shown (positions 344–442). Taken 
from (DENG X, 2009) 
 
B) The structure of STIM1 includes an EF hand and SAM domain NH2-terminal to a single 
trans-membrane (TM) domain; it is believed that, EF hand in particular may be involved in 
sensing ER Ca2+ levels, or in Ca2+ regulation at the plasma membrane. COOH-terminal to 
the TM domain is two coiled-coil (CC) domains, and a serine/proline-rich (S/P Rich) and 
lysine (K Rich) domain. Taken from (PAREKH AB, 2005). 
 
A) 
B) 
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4.2. Receptor operated calcium entry (ROCE) 
 
In non-excitable cells, the most studied pathway for calcium entry is SOC entry pathway or 
CRAC (Calcium Release Activated Calcium Channel) pathway. However, deletion of Orai 
or STIM proteins suggest that there are other pathways of calcium entry and other PM 
calcium channels that might be functionally involved (VIG M, 2008). The term receptor-
operated channel (ROC) was simultaneously proposed, by Bolton (1979) and Van Breemen 
(1978) to define any plasmalemmal channel that is opened as a result of agonist binding to 
its receptor. ROC channels are thought to operate independently of any previous change in 
membrane potential. In smooth muscle cells (SMC), agonists may open ROC channels with 
significant permeability to Ca2+ ions as a result of second messengers produced following 
G alpha-protein activation of PLC (MCFADDEN I, 2002). In SMC and other cell types 
such as hepatocytes and platelets, ATP, ADP, acetylcholine, histamine, vasopressin, 
neurokinin A, and substance P have all been shown to activate receptor operated cation 
influx (ROSADO JA, 2000). ROCs have been described in both visceral (intestine, uterus) 
and vascular (aorta, ear artery, portal vein) smooth muscles and are activated by a large 
variety of agonists.  
 
 TRPC channels constitute a group of Ca2+ permeable cation channels that are activated in 
response to receptor-regulated PIP2 hydrolysis. PIP2 and DAG are antagonist to the TRPC 
binding site. Hence it is hypothesized that a simultaneous increase in DAG levels and 
decrease in PIP2 concentration is necessary for optimal activation of the channel (See 
section 6.1 for details). The TRPC subfamily consists of seven members (TRPC1–TRPC7). 
All of them are not responsible for ROC entry. It was found that, only TRPC3, 6, 7 are 
usually considered to be involved in ROC entry because they are sensitive to DAG and 
other components of GPCR signalling pathways (HOFMANN T, 1999). The mechanisms 
that regulate the activity of the TRPC are not well established and are the subject of several 
studies.  
 
To distinguish between ROC and SOC channels: ROC channel corresponds to a Ca2+ 
permeable non-selective cation channel that is opened by an agonist but is not affected by 
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depleting intracellular Ca2+ stores whereas, SOC channel can be activated without any 
agonist acting on membrane receptors. 
 
4.2.1 TRPC family 
 
The first TRP gene was described in Drosophila (MONTELL C, 1989). Thus 28 TRP have 
been identified and grouped into seven families. These are grouped into following: TRPC 
("C" for canonical), TRPV ("V" for vanilloid), TRPM ("M" for melastatin), TRPN, TRPA, 
TRPP ("P" for polycystic) and TRPML ("ML" for mucolipin). For TRPC, there are 4 sub-
families. The Drosophila trp channel exhibits the greatest homology to the TRPCs. TRPs 
also contain sites for direct phosphorylation by serine/threonine and tyrosine kinases, 
although their role remains to be fully elucidated. The different TRPC families are 
expressed in mammalian cells.  
 
4.2.2 Regulation and binding of TRPCs 
 
As stated earlier, all channels of the TRPC family are activated by stimulation of receptors 
such as GPCRs and RTKs, that activate different isoforms of PLC (CLAPHAM DE, 2003). 
In general, members of the closely related subgroup TRPC3/6/7 can be activated by DAG, 
suggesting that DAG is the PLC-derived product mediating their physiological activation. 
In contrast, TRPC1, 4 and 5, which are also stimulated by receptor mediated PLC 
activation, are completely unresponsive to DAG (VENKATACHALAM K, 2002). 
However, the mechanism by which PLC-mediated TRPC stimulation remains 
controversial. Furthermore, there is evidence that TRPC1, TRPC4/5 and TRPC3/6/7 can 
function as ROC that are mostly insensitive to store depletion (LINTSCHINGER B, 2000); 
(TREBAK M, 2002 ) (PLANT TD, 2003). 
 
4.2.3 Structural characteristic of TRPCs   
 
The common region, domain, motif of TRPC family includes the cytoplasmic N- and C-
termini of TRPCs that are separated by six predicted trans-membrane domains (TM1–
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TM6). The N-terminus of TRPC family includes three to four ankyrin repeats (ANK1–4), a 
predicted coiled coil region (CC) and a putative caveolin binding region(fig. 4) (ENGELKE 
M, 2002) (LEPAGE PK, 2007). A similar motif to Caveolin 1 (Y(x)4F(X)13W) is 
conserved in all members of the TRPC family located in the cytosolic N-terminus adjacent 
to the first transmembrane domain. The cytoplasmic C-terminus includes the TRP signature 
motif (EWKFAR) that is non-selectively permeable to cations, a highly conserved proline 
rich motif (LPXPFXXXPSPK), the CIRB (calmodulin/IP3 receptor binding) region which 
is a calmodulin binding region, and a predicted coiled-coil region (CC). There is a pore 
region (LFW, pore motif) between TM5 and TM6 of TRPC family that is presumed to take 
part in Ca2+ entry. The N- and C- termini are the sites where protein–protein interactions 
take place which are necessary for mediating channel trafficking, anchoring, localization, 
gating, and functional regulation (Fig. 4). However, there is uncertainty as to the exact 
assignment of the first two trans-membrane segment (VANNIER B, 1998) (DOHKE Y, 
2004).  
 
TRPC4 and TRPC5 contain a unique extended C-terminus containing a PDZ binding motif 
responsible for the interaction with the adaptor protein, NHERF, possibly linking the 
channels to PLCβ and the cytoskeleton (fig.4). The first three extracellular loops can be N-
glycosylated. Different levels of constitutive activity within members of the TRPC family 
have been observed due to different patterns of N-glycosylation (VAZQUEZ G, 2004). The 
C-terminus proline-rich motif is presumed to interact with Homer (for TRPC1) and/or 
immunophilins. Moreover, there is another IP3/CaM domain at the C- terminus. The 
TRPC4–IP3R interaction is believe to inhibit by CaM in the presence of Ca2+ (BRAZER 
SC, 2003).  
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Figure 4 Structure of TRPC channels 
The region shaded in gray at the extreme C- terminus is specific for TRPC 4 and 5. The 
CC-C- terminus contains an additional binding region IP3/CaM specific to TRPC4. In CC-
N terminus, the CC region of stathmin is presumed to responsible for the interaction. This 
interaction seemed to be specific for TRPC4 and TRPC5. A proline-rich motif 
(LPXPFXXXPSPK) is thought to be responsible for interaction with Homer (for TRPC1), 
LFW, amino acid motif conserved in the putative pore region of all TRPCs. Taken from 
(VAZQUEZ G, 2004). 
 
4.2.4 Phosphorylation of TRPC channels  
 
TRPCs contain sites for direct phosphorylation by serine / threonine and tyrosine kinases. 
TRPC3 is highly expressed in the brain, as well as in smooth and cardiac muscle cells 
(CLAPHAM DE, 2007) (HOFMANN T, 2000). TRPC3 are receptor operated, DAG-
stimulated channel (HOFMANN T, 1999), which requires src mediated tyrosine 
phosphorylation for its availability for activation whereas Protein kinase G (PKG) was  
reported to have a role in negative regulation of human TRPC3 activity (KWAN HY, 
2004). TRPC1 must be phosphorylated by PKCα in order to be active, which is needed in 
calcium entry (AHMMED GU, 2004). This phosphorylation is essential in the activation of 
SOCE dependent of TRPC1 by PIP2 in the portal vein of rabbit myocytes or in the 
myocytes of rabbit coronary artery (SALEH S, 2009). TRPC4 is phosphorylated on 
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tyrosine residues Y959 and Thr972 in its C-tail by tyrosine kinase of the Src family (STK), 
Fyn kinase (ODELL AF, 2005). The calcium entry is reduced in cells treated with 
inhibitors of tyrosine kinase of the Src family (STK), or in the cells expressing the mutants 
Y959 / 972F of TRPC4 (ODELL AF, 2005). PKC can also phosphorylate TRPC5 on its 
Thr972 site resulting in stimulation of muscarinic receptors upon optimal [Ca+]i levels, 
which desensitize the calcium channel (TRPC5). Inhibition of PKC by the specific inhibitor 
bisindolylmaleimide I (GF1), by inhibitor peptides, or by the expression of the TRPC5 
T972A mutant, prevent or reduces TRPC5 desensitization (ZHU M, 2005). The TRPC6 
interacts with Fyn that is independent of phosphorylation and is mediated by the SH2 
domain of Fyn and the NH2-terminal cytoplasmic domain of TRPC6. Fyn seems to 
modulate the TRPC6 channel properties activated by DAG (HISATSUNE CY, 2004). 
According to Hisatsune et al. (HASSOCK SR, 2002) COS-7 cells overexpressing both Fyn 
and TRPC6 showed tyrosine phosphorylated TRPC6 following EGF treatment. Fyn is also 
able to phosphorylate TRPC6 in an in vitro kinase assay. Finally, Fyn and TRPC6 were 
shown to interact through the SH2 domain of Fyn and the channel N- terminal domain of 
TRPC6 in a manner independent of channel Phosphorylation. These findings contrast with 
those from Hassock et al. who observed no tyrosine phosphorylation of endogenous TRPC6 
in human platelets. Hassock et al. reported that in platelets, endogenous TRPC6 and 
TRPC1 did not undergo tyrosine phosphorylation. The Phosphorylation of TRPC channel is 
important for TRPC channel activation and calcium entry.    
4.3 TRPC6: a potential therapeutic target 
 
Many pathophysiological situations like Focal segmental glomerulosclerosis (FSGS), 
idiopathic pulmonary arterial hypertension, and liver cancer are thought to arise from the 
imbalanced regulation of TRPC6 expression. Thus it is important to understand the 
mechanisms responsible for the regulation of TRPC6. FSGS is a channelopathy associated 
with TRPC6 (WINN MP, 2005) (REISER J, 2005). The symptoms of FSGS include 
proteinuria, hypertension, renal insufficiency, and eventual kidney failure. FSGS carries a 
missense mutation in the TRPC6 gene. In FSGS, TRPC6 mediated calcium signal is 
enhanced in response to agonists such as angiotensin II that promote kidney injury and 
proteinuria. The expression of TRPC6 has been reported to be higher in pulmonary artery 
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smooth muscle cells in Idiopathic pulmonary arterial hypertension (YU Y , 2004) (YU Y , 
2009). An up-regulation of TRPC6 in hepatocytes has also been linked to liver cancer 
(BOUSTANY EL, 2008). 
 
TRPC6, a member of the TRPC family, allows Ca2+ to enter into cells from the 
extracellular medium after stimulation by the PLC/ IP3 pathway. TRPC6 is known to be 
expressed in different types of cells such as vascular smooth muscle cells. The A7r5 cells 
are smooth muscle of rat thoracic aorta cell line use as a cellular model to study the 
function and activation of TRPC6 (JUNG S, 2002). It has been shown that the high 
expression of TRPC6 was essential for calcium entry induced by vasopressin in A7r5 cells 
(JUNG S, 2002). Since TRPC6 is highly expressed in vascular smooth muscle cells, many 
studies have investigated the potential involvement of TRPC6 in pulmonary hypertension.  
 
4.3.1 Mechanism of activation of TRPC6 channel 
 
To date, the complete mechanism of activation of TRPC6 is still unknown. Many 
hypothesis have been proposed for TRPC6 channel activation and thereby calcium entry 
into the cell. 
 
LARGE (LARGE WA, 2009) proposed a scheme for native TRPC6 activation in vascular 
myocytes (Fig. 5). According to his article, PIP2 is bound to TRPC6 in the resting state and 
GPCR stimulation of PLC cleaves PIP2 which simultaneously generates DAG and removes 
PIP2 from TRPC6. They proposed that DAG may be the ligand that causes channel opening 
and that DAG and PIP2 bind to the same site on calmodulin-binding domain within TRPC6 
proteins. DAG and PIP2 have antagonist effects on TRPC6 activity and this model agrees 
with the hypothesis that a simultaneous increase in DAG levels and decrease in PIP2 
concentrations is necessary for optimal activation of TRPC6 (HARDIE RC, 2003). Also, 
depletion of PIP2 using PI(3)K inhibitor, wortmannin and LY294002 only cause transient 
TRPC6 stimulation, indicating that simple removal of PIP2 from TRPC6 is not sufficient 
for TRPC6 channel (MONET M, 2013). The subsequent inhibition of PIP2 in continual 
presence of wortmannin constitutively generates DAG, which is necessary for channel 
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opening. It is therefore hypothesized that simultaneous PIP2 dissociation from TRPC6 and 
DAG association to this PIP2 site or similar site on TRPC6 could maximize TRPC6 
activation and enhanced calcium entry. This also point out that DAG is necessary for 
TRPC6 channel opening (fig. 5). 
 
 
 
Figure 5 Physiological activation mechanism of TRPC6 by AngII in native 
vascularmyocytes. 
(A) At rest endogenous PIP2 is bound to TRPC6 proteins expressed at the plasma 
membrane. (B) Binding of Ang II to AT1 receptors activates G q/11 G-protein subunits 
which stimulate PLC activity and subsequent hydrolysis of PIP2 bound to TRPC6 proteins. 
(C) Optimal activation of TRPC6 channels occurs through both dissociation of PIP2 from 
the channel and association of DAG to the same or a similar site on the channel protein. 
Taken from (LARGE WA, 2009) 
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4.3.2 Trafficking of TRPC6 channel 
 
Stimulation of cells regulates the PM expression of TRPC channels which enhanced Ca2+ 
influx. In HEK-293 cells stably expressing TRPC6, stimulation of muscarinic receptors 
triggers TRPC6 insertion into the plasma membrane, which is retained there as long as the 
stimulus is present (CAYOUETTE S, 2004). Our laboratory previously studied the 
trafficking of TRPC6 channels and showed that the rab GTPases (peripheral membrane 
protein) Rab9 and Rab11 regulate the intracellular trafficking of TRPC6 in Hela cells 
(CAYOUETTE S, 2010). Rab9 is known to participate in the trafficking of proteins to the 
late endosomes and trans-golgi network (TGN) (LOMBARDI D, 1993). TRPC6 has been 
shown to interact and co-localize with Rab9 in vesicular structures (CAYOUETTE S, 
2010). Over-expression of the dominant mutant of Rab9 resulted in an augmentation of 
TRPC6 levels at the PM and consequently, increased the Ca2+ influx upon carbachol (CCh) 
stimulation. Over-expression of Rab11, which is involved in recycling endosomes (REF), 
also increaseTRPC6 channel expression at the cell surface as well as Ca2+ entry 
(CAYOUETTE S, 2010). These results suggest that the intracellular trafficking of TRPC6 
is regulated through the slow endosomal recycling pathway (CAYOUETTE S, 2010). 
 
PI(3)K kinase localized in cytoplasm, phosphorylates PIP2 forming phosphatidylinositol 
(3,4,5)-trisphosphate (PIP3) (FOSTER FM, 2003). The inhibition of PI(3)K by treatment 
with PIK-93, LY294002 or Wortmannin reduces TRPC6 translocation to the PM and 
consequently Ca2+ entry in HEK293 cells stably expressing TRPC6 (T6.11 cells). On the 
other hand, phosphatase and tensin homolog (PTEN) opposes PI(3)K activity by 
dephosphorylating the 3-hydroxyl group of PIP3 to form PIP2. Knockdown of PTEN did 
not affect TRPC6 levels at the cell surface but increased the activity of the channel 
(MONET M, 2012). This demonstrate that PI(3)K  and  the phosphatase PTEN control the 
trafficking and activation of TRPC6 channels. 
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5. Research project 
 
5.1 Problematic 
 
Several studies have previously shown that the dysregulation of TRPC6 expression is 
associated with many pathophysiological conditions such as Focal segmental 
glomerulosclerosis, Idiopathic pulmonary arterial hypertension  (WINN MP, 2005) 
(REISER J, 2005) (HEERINGA SF, 2009) (LEUNG PC, 2006) (SINGH I, 2007) 
(TAUSEEF M, 2012). Studies in our laboratory demonstrated that some TRPC6 
translocates to the plasma membrane after hormonal stimulation (CAYOUETTE S & 
BOULAY G, 2007). However, the mechanisms involved in the intracellular trafficking and 
activation of TRPC6 are yet to be fully characterized. According to several previous studies 
using proteomic analysis (GOEL M, 2005) (BANDYOPADHYAY BC, 2005) many 
proteins have been identified as TRPC6 interacting partners including: Mixovirus 
resistance protein (MxA), Ras homolog gene A (RhoA), syntaxin, clathrin and dynamin 
(DE SOUZA, 2014). 
 
Abnormal activation of the Rho/Rho-kinase pathway has been shown to play a role in 
diseases such as hypertension and bronchial asthma. Recent studies in our laboratory also 
found that there is a potential role of Rho kinase in TRPC6 activation (FRANCOEUR et al, 
unpublished data). These preliminary results showed that when the HEK-TRPC6 cells were 
treated with a Rho inhibitor, CT04 (Cytoskeleton Inc.), CCh induced calcium entry was 
increased by 50%. This increased calcium entry was also observed when ROCK (Rho 
kinase) inhibitors Y-27632 and HA-1077 were used. The Rho kinase can be activated by 
the small G protein RhoA. RhoA can be activated by the heterotrimeric G proteins Gα12 
and Gα13 through the guanosine exchange factors (GEF) p115-RhoGEF, WIDTH or PDZ-
RhoGEF (fig.6A). These results suggest a potential link between Rho kinase and TRPC6. 
 
β-arrestin 1 and β-arrestin 2 have also been  involve in the activation of RhoA (fig. 6B)  
(BARNES WG, 2005)  (Ma X, 2012). It has been demonstrated that β-arrestin 2 act as a 
signal mediator in mitogen-activated protein kinase cascades. Angiotensin II type 1A 
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receptor mediated signaling is dependent on β-arrestin 2 and is mediated by a RhoA/ 
ROCK/MLCK-dependent pathway (CHRISTINA MG, 2010). β-arrestin 1 has also been 
shown to be required to activate the small GTPase RhoA leading to the re-organization of 
stress fibers (RhoA signals through ROCK) following the activation of the angiotensin II 
type 1A receptor (WILLIAM GB, 2004). This activation has been reported to be due to the 
association of β-arrestin 1 with the RhoGAP (a GTPase activating Protein), ARHGAP21. 
This interaction contributed to the inhibition of the RhoGAP activity of ARHGAP21, 
leading to higher RhoA activity (ANTHONY DF, 2011). 
 
Given that our laboratory showed that RhoA could be involved in the regulation of TRPC6 
(ROC), and that Gα12/Gα13 or β-arrestin 1/ β-arrestin 2 are known to be implicated in the 
activation of RhoA, we propose to verify if Gα12/Gα13 or β-arrestin 1/ β-arrestin 2 proteins 
are involved in calcium entry through ROC or SOC in non-excitable cells.  
5.1.1 The Rho/Rho-kinase mediated pathway 
 
The first Rho gene was cloned as a Ras homologue from Aplysia in 1985, soon followed by 
the three human homologues RhoA, RhoB, and RhoC (MADAULE P, 1985). These 
proteins are molecular switches which cycle between an inactive GDP-bound and an active 
GTP-bound state (Fig. 6). Under its active form, Rho interacts with several effectors such 
as Rho-kinase (ROCK), protein kinase N (PKN), rhophilin, rhotekin, citron, p140mDia 
(BISHOP AL, 2000). Rho-kinase, one of the best characterized Rho effectors, exists in two 
isoforms: ROKα (also called ROCK2) and p160ROCK (also known as ROKβ or ROCK1).  
Rho-kinases are serine/threonine protein kinases that contain an amino-terminal catalytic 
kinase domain, a central coiled-coil-domain that binds Rho-GTP, and a C-terminal 
pleckstrin homology domain which is split by a cystein-rich region (LEUNG T, 1995), 
(MATSUI T, 1996). One of the main substrates of Rho-kinase is myosin light chain 
phosphatase. Smooth-muscle myosin light-chain phosphatase (SMPP-1M) is a type I 
serine/threonine phosphatise. SMPP-1M can be inhibited indirectly by a phosphatase 
inhibitor CPI-17  (ETO M, 1995), (SOMLYO AP, 2000). CPI-17 is a phosphorylation 
dependent inhibitor protein of smooth muscle myosin phosphatase. In addition, CPI-17 
independent phosphorylation of Rho-kinase can directly phosphorylate MLC20 (AMANO 
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M, 1996) and causes the smooth muscle contraction. The smooth muscle relaxation is 
opposed by the inhibition of SMPP-1M by CPI-17. Recently it has been shown that Rho 
might also cause phosphorylation of CPI-17 via its effectors protein kinase N (PKN) 
(HAMAGUCHI T, 2000) and Rho-kinase (KOYAMA M, 2000).  
 
Figure 6 Regulation of Rho activity by Gα12/Gα13 or β-arrestin 1/ β-arrestin 2 
A) Various classes of signaling receptors have been shown to activate Rho through the 
regulation guanine nucleotide exchange factor (GEF) proteins which catalyze the exchange 
of GDP for GTP on Rho GTPases. Two negative regulators of Rho activity, GTPase-
activation proteins (GAP) and GDP-dissociation inhibitors (GDI) may also be regulated by 
receptor-mediated signals. Effector proteins of Rho are PKN (Protein kinase N); p140mDia 
(Mammalian homolog of Drosophila diaphanous); citron (citron-kinase) 
(WETTSCHURECK N, 2002).  
 
 
B) β-arrestin-dependent signaling to RhoA or ERK1/2.  β-arrestin 1 and Gαq/11 is 
involved in activation of Rho. Activation of RhoA leads to stress fiber formation via the 
downstream effector of RhoA, ROCK. Both arrestins and heterotrimeric G protein 
activation is required to activate Rho. Conversely, β-arrestin 2 signals to the MAPK 
component ERK1/2 independent of the heterotrimeric G protein pathway to ERK1/2 via 
PKC. Therefore, RhoA activation depends on heterotrimeric G protein and β-arrestin 1, 
however and ERK1/2 activation is independent on heterotrimeric G protein-independent 
and depends on β-arrestin 2. 
A) 
B) 
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5.1.2 Regulation of Rho/Rho-kinase 
 
The activity of Rho itself is regulated by three groups of proteins, which are found 
ubiquitously (Fig. 6): GTPase activating proteins (GAPs) which facilitate the inactivation 
of active GTP-bound Rho by increasing its intrinsic GTPase , GDP dissociation inhibitors 
(GDIs) which inhibit the dissociation of GDP and indirectly prevent Rho to translocate on 
the membranes (OLOFSSON B, 1999), and Rho-specific guanine nucleotide exchange 
factors (RhoGEFs) which facilitate the activation of Rho by promoting the dissociation of 
GDP and subsequent binding of GTP. Currently RhoGEF proteins are regarded as the main 
regulators of Rho activity.  
 
The activity of Rho can also be regulated by numerous GPCR such as Gq/11, and it is well 
established that G-proteins of the Gα12 family, Gα12 and Gα13, which appear to be 
ubiquitously expressed, are involved in these GPCR activation of Rho (BUHL AM, 1995 ). 
A group of RhoGEFs have been identified to bind the activated α-subunit of Gα12/ Gα13, 
including  p115RhoGEF/lsc, PDZ-RhoGEF, and LARG(fig.6). However, other receptors 
such as growth factor receptor, cytokine receptor, integrins are believed to take part in Rho 
activation through the activation of GEF. However, these receptors involvement in GEF 
activation is not confirmed yet (WETTSCHURECK N, 2002). 
 
5.1.3 β-arrestin mediated signalling  
 
β-arrestin 1 and β-arrestin 2 (non-visual arrestins, also known as arrestin 2 and arrestin 3), 
are ubiquitously expressed in most tissues and play an important role in regulating signal 
transduction by numerous GPCRs (ATTRAMADAL H, 1992; REITER E, 2006).  Both of 
these β-arrestin isoform are 78% sequence homologous (ATTRAMADAL H, 1992).  β-
arrestin 1 and β-arrestin 2 accumulate in the cytoplasm following their overexpression. β-
arrestin 2 has a leucine rich nuclear export sequence located on its C terminus, that is 
absent in  β-arrestin 1. Hence, β-arrestin 1 but not β-arrestin 2, accumulates in the nucleus, 
and shows differences in nucleocytoplasmic shuttling (SCOTT MG, 2002).  Both the β-
arrestin 1 (418 amino acids) and β-arrestin 2 (410 amino acids) have nuclear localization 
sequences on their N termini. β-arrestin 1 and β-arrestin 2 can reciprocally regulate 
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signaling at certain receptors. For example, siRNA knockdown of β-arrestin 2 attenuates 
ERK signaling, whereas knockdown of β-arrestin 1 potentiates ERK signaling (AHN S, 
2004). However, at other receptors such as the β2AR and the type 1 parathyroid hormone 
receptor (PTH1R), knockdown of either β-arrestin 1 or β-arrestin 2 decreases ERK 
signaling (SHENOY SK, 2006).  
 
The classical role of β-arrestins includes their role in GPCR signaling and in signaling on 
endosome through MAPK activation. β-arrestins are belived to quench the GPCR signaling 
by sterically inhibiting the G protein interaction at the second and third intracellular loops 
of a GPCR (DEGRAFF JL, 2002) (MARION S, 2006). This steric hindrance uncouples 
GPCRs from the G protein signal transduction process (FERGUSON SS, 1996). 
Association of β-arrestins with the phosphorylated domains of the 7TMR trigger 
conformational changes in the GPCR at PM that allows β-arrestins to recruit clathrin and 
adaptor protein (AP-2). However, β-arrestins require C-terminal dephosphorylation for 
targeting internalized receptors to clathrin. This leading to the co-localization of the GPCR 
and β-arrestin in punctuated clathrin-coated pits at the cell surface or near. As a result, 
receptor desensitization via downstream kinases (MAPK) takes place (REITER E, 2012), 
(SHUKLA AK, 2011). Thus, another role of β-arrestins being as adaptor proteins that 
facilitate the activation of mitogen-activated protein kinase cascades (MAPK cascades). 
MAPK cascade relays signals from the PM to the nucleus. β-arrestins scaffold the MAPK 
signaling molecules (ERK), leading to phosphorylation and activation of extracellular 
signal mediated kinase (ERK 1/2) (DEWIRE, 2007). Ubiquitination of β-arrestin – GPCR 
complex prolongs the MAPK activity. Once internalized, the receptor continues for 
tubulovesicular early endosomes, where receptors are sorted to either recycling endosomes 
or multivesicular late endosomes. GPCRs in early endosome return to the plasma 
membrane. GPCRs in multivesicular late endosomes, traffic receptors to lysosomes for 
degradation (KANG D, 2014).  In brief, the key roles of β-arrestins are to 1) inhibit the 
coupling of GPCR to the G-proteins and 2) recruit AP2 and clathrin to internalize the 
recptor in clathrin-coated vesicles, and 3) endosomal signaling (MAPK cascade).   
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β-arrestin 1 and β-arrestin 2 has also been involve in the activation of RhoA (WILLIAM 
GB, 2004) (CHRISTINA MG, 2010). It has been demonstrated that β-arrestin 2 act as a 
signal mediator in mitogen-activated protein kinase cascades. Angiotensin II type 1A 
receptor mediated signaling is dependent on β-arrestin 2 and is mediated by a RhoA/ 
ROCK/MLCK-dependent pathway (CHRISTINA MG, 2010). β-arrestin 1 has also been 
shown to be required to activate the small GTPase RhoA leading to the re-organization of 
stress fibers (RhoA signals through ROCK) following the activation of the angiotensin II 
type 1A receptor (WILLIAM GB, 2004). This activation has been reported to be due to the 
association of β-arrestin 1 with the RhoGAP (a GTPase activating Protein), ARHGAP21. 
This interaction contributed to the inhibition of the RhoGAP activity of ARHGAP21, 
leading to higher RhoA activity (ANTHONY DF, 2011). Moreover, β-arrestin 2 involve in 
translocation of p115RhoGEF, a regulator of RhoA to the PM from the cytosol. Hence, β-
arrestins are believed to serve for diverse upstream signals to activate RhoA. For example, 
angiotensin II type 1A receptor-induced activation of RhoA require both Gq and β-arrestin 
1(fig.xx) (BARNES WG, 2005).  However, β-arrestin 2 signals to the MAPK component 
ERK1/2 independent of the heterotrimeric G protein pathway via PKC (fig.xx). Consequent 
activation of RhoA promotes the formation of focal adhesions and stress fibers (fig.xx). 
Overall, it seems that β-arrestins finetune RhoA activity through coordinated regulation of 
RhoA activators and inactivators.  
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5.2 Hypothesis  
 
Given that RhoA has been shown to be activated by heterotrimeric G proteins Gα12 and 
Gα13 or by β-arrestin 1 / β-arrestin 2 proteins, and TRPC6 channel expression at the 
plasma membrane can be regulated by the RhoA/ROCK pathway (FRANCOEUR et al, 
unpublished data), we hypothesized that Gα12 / Gα13 and/or β-arrestin 1 / β-arrestin 2 are 
involved in RhoA activation in ROCE. Since RhoA can be activated by β-arrestins, we 
assume that β-arrestins can also modulate the SOCE pathway.  
 
5.3 Objective of the study: 
 
Objective 1: Determine if Gα12 and/or Gα13 protein influence the receptor operated 
Ca2+ entry through TRPC6 channel in vascular smooth muscle cells (A7r5) 
 
The entrance of calcium via ROC was examined in vascular smooth muscle cells (A7r5) 
(expressing endogenous TRPC6) in which Gα12 or Gα13 were depleted using siRNA.  
 
 Objective 2: Determine if β-arrestin 1 and β-arrestin 2 influence the receptor 
operated (TRPC6) or store-operated Ca2+ entry (Orai1) in HEK 293T cells and 
HEK293 cells stably transfected with TRPC6 (T6.11 cells) 
 
The entrance of calcium via SOCE was examined in HEK 293T cells and HEK293 cells 
stably transfected with TRPC6 (T6.11 cells) in which β-arrestin 1 or β-arrestin 2 were 
depleted using siRNA.  
 
Objective 3: Determine if β-arrestin 1 and β-arrestin 2 interact with STIM1 or Orai1 
protein to influence the store-operated Ca2+ entry (Orai1) in HEK 293T cells and 
HEK293 cells stably transfected with TRPC6 (T6.11 cells) 
 
A co-immunoprecipitation assay was performed in HEK293T cells in which β-arrestin 1 
was depleted using siRNA. Immunofluorescence assay was performed to examine the 
distribution of Orai1 or STIM1 protein in β-arrestin 1 and β-arrestin 2 depleted cells 
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MATERIAL AND METHODS 
 
6. Material  
Table: List of products used 
 
Products  Manufacturer  
Antibody Anti-Gα12 Santa cruz biotechnology, inc. 
Antibody Anti-Gα13 Santa cruz biotechnology, inc. 
Antibody Anti β-arrestin 1 AbCam (Cambridge, MA, USA) 
Antibody Anti β-arrestin 2 Cell Signaling Technology (Boston, MA) 
Antibody anti-ST1M1 (Rabbit 
polyclonal) 
Millipore (Temecula, CA, USA) 
Antibody Anti-Actin Millipore (Temecula, CA, USA) 
Anti-Myc Santa Cruz Biotechnology (Dallas, TX) 
Arginin vasopressin (AVP)  Calbiochem (San Diego, CA) 
Bradford reagent  BioRAD 
BSA Sigma-Aldrich  
Carbachol (CCh)  Calbiochem (San Diego, CA) 
DMEM  Life Technologies Corporation 
EGTA Sigma-Aldrich (St. Louis, MO, USA) 
Fetal bovine serum (FBS) Invitrogen (Burlington, ON) 
Fura-2 / AM  Calbiochem (San Diego, CA)  
G418 Invitrogen (Burlington, ON) 
Hepes Invitrogen (Burlington, ON) 
HRP conjugated sheep anti-mouse 
IgG 
  
GE Healthcare UK Limited 
HRP conjugated donkey anti-rabbit 
IgG 
GE Healthcare UK Limited 
L-glutamine Invitrogen (Burlington, ON) 
LipofectAMINE 2000  Invitrogen (Burlington, ON) 
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Nitrocellulose membrane   Perkin Elmer (Boston,MA) 
Opti-MEM I Invitrogen (Burlington, ON) 
Protein A-sepharose beads  Santa Cruz Biotechnology (Santa Cruz,  
CA, USA) 
Penicillin/streptomycin Invitrogen (Burlington, ON) 
Para-formaldehyde (PFA) Electron Microscopy Science (Hatfield,  
PA) 
SiRNA Control (ON-TARGET plus 
Control Pool)  
Dharmacon, Inc. (Lafayette, CO, USA) 
SiRNA Arrb1 Dharmacon, Inc. (Lafayette, CO, USA) 
SiRNA Arrb2 Dharmacon, Inc. (Lafayette, CO, USA) 
SiRNA Gα12 Dharmacon, Inc. (Lafayette, CO, USA) 
SiRNA Gα13 Dharmacon, Inc. (Lafayette, CO, USA) 
SiRNA Orai1 Dharmacon, Inc. (Lafayette, CO, USA) 
Trypsin Invitrogen (Burlington, ON) 
Triton X-100  Sigma-Aldrich 
Tween 20 Fisher Chemical 
Tris HCl Sigma-Aldrich 
West Pico Chemiluminescent Reagent Thermo scientific (Rockford, IL) 
 
  
 
Unless otherwise stated, all other reagents were from Laboratoire MAT (Quebec City, QC, 
Canada). 
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METHODS 
 
7.1 Cell culture and Transfection  
 
HEK293T as well as A7r5 vascular myocytes were maintained at subconfluence in 
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum, 2 mM 
L-glutamine, 50 units/ml penicillin, and 50 g/ml streptomycin at 37°C in a humidified 
atmosphere containing 5% CO2. T6.11 cells which are HEK293 cells stably transfected 
with mouse TRPC6 were cultured in the same medium supplemented with 400 g/ml G418. 
200 000 cells were plated in each well of 6-well culture dishes and incubated overnight at 
37°C in a humid atmosphere containing 5% CO2. Transient transfection was performed by 
using the transfection reagent LipofectAMINE 2000. The various siRNA’s of 50 nM were 
pre-diluted in 250 ul of OptiMEM I. Lipofectamine 2000 (10 μl) were then diluted in 250 
μl of Opti-MEM I previously mixed to SiRNA. The mixtures were incubated for 20 min at 
room temperature and were then added to A7r5, T6.11, or HEK293T cells. A7r5 and 
HEK293T cells were then incubated in DMEM without antibiotics at 37°C in a humid 
atmosphere containing 5% CO2 for 24 hours. T6.11 cells were incubated in DMEM without 
antibiotics at 37°C in a humid atmosphere containing 5% CO2 for 5 hours. After this 
period, the culture medium was replaced by DMEM 10% FBS with antibiotic. For 
measurements of [Ca2+]i, each wells of transfected cells were trypsinized and the contents 
of each well were distributed on three cover slips pretreated with 0.1 mg/ml poly-L-lysine. 
For the immunoprecipitation, the contents of three wells of transfected cells were 
trypsinized and redistributed in a 60 mm petridish or three small petridish were combined 
in one petridish of 10 cm. In all cases, the cells were incubated for an additional 24-48 
hours at 37°C in a humidified atmosphere containing 5% CO2. For confocal microscopy, 
HEK293T cells were transfected with siRNA using LipofectAMINE 2000. 24 hour after 
siRNA transfection, 1µg/µl of STIM1-YFP or Orai1YFP tagged protein was incorporated 
into the cells. Confocal microscopy analysis was done 24h after the DNA transfection.  
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7.2 Protein Extractions 
 
T6.11and HEK293T cells were lysed in 6-well culture dishes. For A7r5 cells, cell lysis was 
performed in 10 cm petridish. 500 µl (in T6.11, HEK293T cells ) and 1 ml (in A7r5 cells) 
of ice-cold lysis buffer used (1.25% Nonidet P-40, 1.25% sodium deoxycholate, 2 mM 
EDTA, 12.5 mM sodium phosphate, pH 7.2, 1 g/ml soybean trypsin inhibitor, 5g/ml 
leupeptin, 100 M phenyl methyl sulfonyl fluoride, PMSF) for 30 min on ice with gentle 
agitation. They were then scraped and transferred into a 1.5 ml Eppendorf tube. The cell 
lysates were homogenized by 20 passages with a 20-gauge needle and 10 passages within a 
25-gauge needle. The samples were centrifuged at 13 000 g for 20 min at 4°C to remove 
cellular debris. The supernatant containing proteins from the lysate was then stored at -
80°C until use. 
 
7.3 Determination of protein concentration 
 
Determining the protein concentration in the cell lysates was performed using a Bradford 
protein assay (BARDFORD, 1976). The technique was used to determine the protein 
concentration of the sample by comparison with a calibration curve obtained with albumin 
protein (BSA) under the same conditions. The calibration curve made with doses of 0, 5, 
10, 15, 20 and 25 μg of BSA. Then, a volume of 2 μl of protein sample was added to a 
volume of sterile water to obtain a total volume of 800μl. Then 200μl of Bradford reagent 
was added to obtain a final volume of 1000μl. The intensity of staining was evaluated by 
spectrophotometry at a wavelength of 595nm.  
 
7.4 Separation of the proteins by electrophoresis on polyacrylamide gel and 
immunodetection of proteins 
 
Between 50 – 60 µg of β-arrestin 1 / β-arrestin 2 protein or 50 - 65 µg of Gα12 / Gα13 
protein were diluted in lameli sample buffer; then loaded onto a polyacrylamide gel (SDS-
PAGE) to allow separation of proteins according to their molecular weight. A concentrated 
gel of 5% acrylamide (in a Tris HCl buffer 1.0 M, pH 6.8) and a separating gel of 6 to 10% 
acrylamide according to the molecular weights (in a buffer Tris HCl 1.5 M, pH 8.8) were 
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used. Proteins were separated using a 1.5 mm thickness MINI-PROTEAN-II system 
BioRad. The gels were placed in a chamber containing running buffer and prepared 
samples with 2X laemmli were placed in each well. Proteins were separated (either 80mA 
or 40 mA depending on the number of gels) until the front migration comes out  of the 
separator gel. After migration, the gels were then transferred onto a 0.2 um nitrocellulose 
membrane (400 mA for 2 h or 100 mA overnight in 150 mM glycine, 20 mM Tris-base, 
20% methanol) for immunoblotting. After staining with Ponceau S, the blots were washed 
with Tris Buffered Saline with Tween (TBST) and were incubated for 16 h at 4°C in 5% 
non-fat skim milk in TBST. After blocking of non-specific sites, membrane were incubated 
for about 16-20h h at 4°C in TBS-Tween buffer with 5% milk and appropriately diluted 
specific antibody (anti-Gα12: 1/200, anti-Gα13:1/100, anti β-arrestin 1: 1/500, anti β-
arrestin 2: 1/1000, anti-STIMl: 1/200). After incubation in 1st antibody, the membranes 
were washed three times for 5 minutes each in TBS-Tween and then incubated in a solution 
of TBS-Tween-milk 5% with a secondary antibody conjugated to HRP diluted 1/10000 for 
2 hour at room temperature with mild agitation. Next, the membranes were washed three 
times with TBS-Tween. The immune complexes were detected using Western Lightning 
Chemiluminescence Reagent Plus kits.  
 
7.5 Co-immunoprecipitation  
 
50 µl of Protein A Sepharose beads (50% slurry, pre-equilibrated in RIPA buffer) were 
coupled with 1 µg/µl of anti- β-arrestin 1 antibody, 0.35 µg/µl of anti-IgG or 1µg/µl of anti-
myc for three hours in RIPA buffer at 4°C. This IgG are heavy light chain antibody from 
rabbit. IgG pre-coupled beads were blocked with 0.1% of BSA for 30 minutes at 4°C. Then 
the beads were washed three times with cold-ice RIPA in the section 7.2 and added to the 
360 µl of supernatant. The immunoprecipitation was carried out at 4°C for 16 h. Samples 
were centrifuged for 1 minute at 2000 rpm at 4°C and beads were then washed four times 
with 1 ml of ice-cold lysis buffer (RIPA). During the last washing with RIPA buffer, 
maximum of the supernatants were removed, beads were resuspended in 50 µl of laemmli 
(2×) and 10% β-mercaptoethanol and heated for 30 minutes at 65°C before SDS-PAGE 
preparation and immunoblotting. Then the proteins were resolved by SDS-PAGE and 
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transferred to nitrocellulose membranes. Finally western blot was performed as described 
above in section 7.4. 
7.6 Confocal microscopy 
 
β-arrestin 1 or β-arrestin 2 knocked down HEK293T cells were transfected with either 1 µg 
of mouse Orai1-YFP or 1 µg of mouse STIM1-YFP (from addgene).The cells were then 
washed twice with PBS at room temperature and fixed with ice-cold 3% PFA in PBS for 30 
min at room temperature. Then the cells were washed twice in PBS and treated with 50 mM 
NH4Cl for 10 min. Cells were then permeabilized with 0.1% Triton X-100 in PBS for 10 
min at room temperature followed by three times washes with PBS 1X. The coverslips 
were examined using an inverted confocal laser-scanning microscope (FV1000, Olympus). 
Laser intensity and detector sensitivity settings were kept constant for all images 
acquisitions. Olympus Fluoview software version 1.6a was used for image acquisition and 
analysis. Images were further processed with Adobe Photoshop software (Adobe Systems, 
San Jose, CA, USA).  
 
7.7 Measurement of [Ca2+]i 
 
After 24 hour of transfection, cells were placed on cover slips. Then, the cells were rinsed 
with HBSS buffer (120 mM NaCl, 5.3 mM KC1, 0.8 mM MgSO4, 5 mM Glucose, 20 mM 
HEPES, 1.8 mM CaCl, pH 7.4) and incubated for 20 minutes in the dark at room 
temperature in HBSS buffer containing 0.4 μM Fura2-AM. After washing, the cells were 
incubated for 20 minutes in HBSS buffer to allow de-esterification. The cover slips were 
then mounted in a circular open-bottom chamber and were placed on the stage of an 
Olympus 1X71 microscope (Olympus Canada Inc., Markham, ON, Canada) equipped with 
a Lambda-DG-4 illuminator (Sutter Instrument Company, Novato, CA, USA). [Ca2+]i in 
selected fura 2-AM loaded cells were measured by fluorescence videomicroscopy at room 
temperature using alternating excitation wavelengths of 340 nm (26 nm bandpass) and 387 
nm (11 nm bandpass) and emission was measured at a wavelength of 510 nm. The ratio of 
fluorescence emitted by excitation at 340 nm relative to that emitted at 387 nm was 
calculated and used to quantify the Ca2+ according to the method of Grynkiewicz 
(GRYNKIEWICZ G, 1985). 
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At time 0, the cells were incubated in the presence of HBSS, and 30 seconds after, calcium 
were removed from the medium by adding a solution infusion HBSS without calcium and 
containing 0.5 mM EGTA. After a 30 second period in the absence of extracellular Ca2+, 
the cells were stimulated with 100 nM of AVP in A7r5 cells, 10 µM CCh or 50 µM CCh in 
T6.11 cells and 1 µM of Tg in HEK293T cells. During stimulation, the cells were still 
lacking extracellular Ca2+. Once the [Ca2+] i returned to basal level, calcium entry was 
produced and measured by adding HBSS containing 1.8 mM CaCl2 and 10 µM CCh or 50 
µM CCh or 100 nM of AVP or 1 µM of Tg according to the cell lines tested. Only the cells 
that have demonstrated calcium release were considered for calcium imaging analysis and 
were used in the statistical analysis. [Ca2+]i values were recorded every second. The results 
were represented as a mean ± standard deviation (SD) obtained from 8-9 cover slips in each 
condition, and each of the cover slips containing 45-65 transfected HEK293T or T6.11 cells 
and 15-25 A7r5 cells.  
 
7.8 Statistical Analysis 
 
Results were expressed as mean ± SD and were calculated from at least three experiments 
independent. To determine the significance of the results, the Student test was used with a 
confidence level of 95% (p <0.05). 
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RESULTS 
 
8.1 Importance of Gα12 and Gα13 in Ca2+ entry through ROCE  
 
The involvement of endogenous Gα12 and Gα13 in the cellular Ca2+ entry of A7r5 cells 
was investigated by reducing their expression with siRNA specific for Gα12 or Gα13 
mRNA. Figure 7 shows reduced endogenous expression of Gα12 or Gα13 in A7r5 cells. 
The transfection of A7r5 cells with siRNA specific to Gα12 or Gα13 decreased their level 
of expression to 66.1 ± 7.2 % and 22.4 ± 20.2 % respectively compare to the level in cells 
transfected with a control siRNA (sicontrol) (Fig. 7). Given that Gα12 and/or Gα13 are 
involved in Rho activation (WETTSCHURECK N, 2002) and that Rho is suggested to 
activate ROCE through TRPC6, we investigated whether knocking down of Gα12 or Gα13 
protein would affect the intracellular [Ca2+]i in A7r5 cells. The Ca
2+ release was evaluated 
following an incubation of the cells with 100 nM AVP in the absence of extracellular Ca2+ 
at t=30 seconds. AVP binds to V1-vasopressin receptor, in A7r5 cells (THIBONNIER M, 
1991) and presumably regulates Ca2+ transport pathway via stimulation of IP3 formation. 
The knockdown of Gα12 or Gα13 did not modify AVP-induced Ca2+ release. The level of 
[Ca2+]i  reaches to 340 nM as shown in figure 8. The decline in [Ca
2+]i after calcium release 
is presumably due to Ca2+ leaving the cells through several calcium transport proteins on 
PM. 90 seconds after AVP stimulation, at t=150 seconds, external Ca2+ was restored. At 
this point, we expected to see the entry of calcium from the extracellular space. Figure 8 
shows AVP-induced Ca2+ entry in cells transfected with sicontrol (blue line), siGα12 (red 
line) and siGα13 (green line). In our experiment, the KD Gα12 and Gα13 in A7r5 cells did 
not modify AVP-induced Ca2+ entry. Furthermore, the [Ca2+]i level were observed 112 ± 15 
nM and 113 ± 8 nM in Gα12 and Gα13 KD A7r5 cells respectively compared to 118 ± 7 
nM in control cells. This result suggests that knocking down Gα12 and Gα13 in A7r5 cells 
does not impact in AVP induced ROCE (TRPC6 channel).  
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Figure 7 The expression of Gα12 and Gα13 is greatly diminished by small interference 
RNA in vascular myocytes, A7r5 
A) A7r5 cells were transfected with 50 nM of siRNAs against Gα12, Gα13 or a control. 
Cells were lysed with RIPA after 72 h and 1.80 µg of each protein were subjected to SDS-
PAGE electrophoresis. Immunoblotting and immunodetection of Gα12, Gα13 and actin 
shown in this figure. sicontrol: cells transfected with siRNA having non-specific sequence, 
siGα12: cells transfected with siRNA directed against Gα12, siGα13: cells transfected with 
a siRNA directed against Gα13. The molecular size of reference protein is shown in left. B) 
The bar graph represents the % relative expression of proteins (Gα12, Gα13) compared to 
actin.  These typical experiences are representative of three experiments that gave similar 
results. *p < 0.05 
 
 
 
A) 
B) 
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Figure 8 Calcium imaging in A7r5 cells treated with control Gα12 and Gα13 siRNA 
 
The decrease of expression of Gα12 and Gα13 in A7r5 does not alter the Ca2+ entry 
induced by100 nM AVP. A7r5 cells transfected with specific siRNA for 72h were loaded 
with 1µM Fura-2-AM and incubated for 30 sec in the absence of Ca2+ (in the presence of 
0.5 mM EGTA) before stimulation with 100 nM AVP. Extracellular Ca2+ (1.8 mM) was 
restored after 150 sec and stimulated with 100 nM AVP. The graph represents the mean 
values for each condition (n=3) of a representative experiment. In each conditions, ~200 
000 A7r5 cells were splited into three coverslips. The blue lined curve represents sicontrol, 
red lined curve represents siG Gα12 and green lined curve represents siGα13. 
 
8.2 Knocking down β-arrestin 1 / β-arrestin 2 does not change in CCh induced 
calcium entry through ROC in HEK 293 cells stably expressingTRPC6 (T6.11) 
 
To investigate the involvement of β-arrestin 1 and β-arrestin 2 in the modulation of Ca2+ 
entry in T6.11 cells, we used siRNA technology to knockdown their expression level. As 
shown in figure 9, siRNA specific to β-arrestin 1 or β-arrestin 2 reduced their endogenous 
expression levels by 62.4 ± 23.2 % and 57.1 ± 18.9 % respectively. Moreover, siRNA 
against β-arrestin 1 did not significantly alter the level of expression of β-arrestin 2. 
Similarly, siRNA against β-arrestin 2 did not significantly alter the level of expression of β-
arrestin 1, indicating the high specificity of these siRNAs (Fig. 12).   
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Determination of Ca2+ entry in T6.11 cells were performed by using Ca2+ depletion/ Ca2+ 
readdition protocol (BOULAY G, 1997). The siRNA transfected T6.11 cells were treated 
with the fura-2AM for 20 min, in HBSS in presence of Ca2+. The medium was replaced by 
a medium without Ca2+ (with EGTA) for 30 seconds. After 30 seconds, the cells were 
stimulated with 1 µM Thapsigargin (Tg) to induce intracellular Ca2+ emptying. Stimulation 
with Tg blocks the SERCA pump located in ER and then Ca2+exits the ER presumably 
through leak pathways. As a result, the [Ca2+]i  reaches ~125 nM as shown in figure 10A). 
The decline in [Ca2+]i after calcium release is presumably due to Ca
2+ leaving the cells 
through several calcium transport proteins  on the PM. As a result, the ER is approximately 
emptied by 360 seconds.     
 
Once the [Ca2+]i had returned to the basal level 300 seconds after Tg stimulation, the 
extracellular medium was restored with 1.8 mM CaCl2 with Tg still present. In our 
experiment, increased Tg-induced Ca2+ entry (SOCE) were observed in β-arrestin 1 and β-
arrestin 2 KD cells compared to that of sicontrol. As shown in figure 10A, after the 
extracellular Ca2+ was restored at 360 sec, the maximum [Ca2+]i reach to 182 ± 18 nM and 
207 ± 39 nM in β-arrestin 1 and β-arrestin 2 KD cells respectively. In cells transfected with 
the sicontrol, the maximum [Ca2+]i reaches to 142 ± 7 nM.  Since the ER is depleted, the 
Ca2+ entry must almost certainly come from outside the cell across the PM presumably due 
to SOCE.  As a result, it appears that SOCE is enhanced with KD of the arrestins (fig. 
10A). Therefore, these results indicate (or strongly suggest) that this SOCE is enhanced 
with KD of the arrestins. Tg induced Ca2+ entry following the restoration of external Ca2+ 
was significantly increased by 25 % and 50% for β-arrestin 1 and β-arrestin 2 KD cells, 
respectively, compared to that of sicontrol (Fig. 10B). In summary, these results indicate 
that the arrestins are involved in limiting or controlling SOCE. 
 
180 seconds after SOCE activation (t=480 seconds) (fig. 10A), the T6.11 cells were 
stimulated with 50 µM CCh in the presence of external Ca2+ (fig.10A). At this point, the 
ER was still essentially depleted of Ca2+ since Tg stimulation was present just up to the 
time t=480 seconds before the addition of CCh. Addition of CCh causes an additional Ca2+ 
entry due to the activation of ROCE (TRPC6) (BOULAY G, 1997). It is noted that while 
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CCh can cause Ca2+ release from the ER, this possibility is more or less ruled since the ER 
should be depleted of Ca2+ as noted above. Net Ca2+ entry was calculated by subtracting the 
basal [Ca2+] level just before CCh stimulation from the maximum [Ca2+] level recorded in 
response to CCh. In β-arrestin 1 and β-arrestin 2 KD cells, activation of ROCE by CCh at 
t=480 seconds have resulted in an increased level of [Ca2+]i of 59 ± 6 nM and 64 ± 27 nM 
respectively. This increase level of [Ca2+]i was similar to that of 63 ± 20 nM in sicontrol-
transfected cells. These results, expressed as % change from sicontrol (fig. 10C), indicate 
that net Ca2+ entry associated with CCh stimulation remains unchanged in β-arrestin 1 and 
β-arrestin 2 KD cells compared to sicontrol cells (Fig. 10C). In conclusion, in contrast to 
the case of SOCE mentioned above, arrestins are not involved in regulating ROCE. 
 
Determination of Ca2+ entry in T6.11 cells was also performed by using Ca2+ depletion/ 
Ca2+ readdition protocol (BOULAY G, 1997) at a lower doses of CCh (10 µM) to see the 
modification in calcium entry. The siRNA transfected T6.11 cells were treated with the 
fura-2AM for 20 min, in HBSS in presence of Ca2+. The medium was replaced by a 
medium without Ca2+ (with EGTA) for 30 seconds. After 30 seconds, the cells were 
stimulated with 10 µM CCh. As shown in Fig. 11A, in the absence of Ca2+, the CCh-
induced Ca2+ release was similar in control and in β-arrestin 1 and β-arrestin 2 KD cells. 
Upon addition of 1.8 mM CaCl2 to cells in presence of CCh stimulation, the [Ca
2+]i remains 
unchanged. The [Ca2+]i level were detected in si β-arrestin 1 depleted cells 164 ± 35 nM 
and si β-arrestin 2 depleted cells 157 ± 21 nM compared to sicontrol: 147 ± 28 nM 
(fig.11A).  Net Ca2+ entry was calculated by subtracting the basal Ca2+ level from the 
maximum Ca2+ level recorded once external Ca2+ had been restored. The result did not 
show a significant difference in the β-arrestin depleted cells and control cells (fig. 11B). β-
arrestin 1 and β-arrestin 2 seem not to implicate in ROCE. 
 
Based on these results we conclude that the depletion of β-arrestin 1 and β-arrestin 2 does 
not alter the calcium entry through ROCE (TRPC6) into the T6.11 cells however, they 
seem involved in the calcium entry through SOCE. 
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Figure 9 The expression of β-arrestin 1 and β-arrestin 2 are reduced in siRNA treated 
T6.11 cells 
 
T6.11 cells were transfected with 50 nM of control, β-arrestin1 and β-arrestin 2 siRNAs, 
lysed after 48h and loaded in 10% gel SDS-PAGE. The molecular size of reference protein 
is shown in left. The bar graph below represents the % relative expression of proteins 
compared to actin.  Relative expression of β-arrestin 1 and β-arrestin 2 represented on bar 
graph. The results are expressed in mean ± SD of 3 independent experiments. *p < 0.05 
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Figure 10 Reduced level of expression of β-arrestin 1 and β-arrestin 2 in T6.11 cells 
increases Thapsigargin induced Ca2+ entry through SOCE and do not change in 
carbachol induced Ca2+ entry through ROCE 
A) T6.11 cells were transfected to 50nM of β-arrestin 1 or β-arrestin 2 siRNAs, sicontrol. 
β-arrestin 1 and β-arrestin 2 are abbreviated as arrb1 or arrb2 respectively in the graph. 
After 48h of transfection, cells previously loaded with Fura-2-AM were incubated for 30 
sec in the absence of Ca2+ (in the presence of 0.5 mM EGTA) and were then stimulated 
with 1 µM Tg. Extracellular Ca2+ (1.8 mM) was restored at t=360 sec with the presence of 
Tg stimulation. At t=480 sec, the extracellular Ca2+ (1.8 mM) was restored with the 
presence of stimulation of CCh. The blue lined curve represents sicontrol, red lined curve 
represents si β-arrestin 1 and green lined curve represents si β-arrestin 2. B) Net Ca2+ entry 
were calculated by subtracting the [Ca2+]i level at t=360 sec from the maximum [Ca
2+]i 
level recorded once external Ca2+ had been restored with Tg stimulation. C) Net Ca2+ entry 
were also calculated by subtracting the [Ca2+]i level at t=480 sec from the maximum [Ca
2+]i 
level recorded once external Ca2+ had been restored with CCh stimulation. B) C) The 
histogram represents the average ± S.D. of three independent experiments.  
 
 
 
 
A) 
B) 
C) 
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Figure 11 Reduced level of expression of β-arrestin 1 and β-arrestin 2 in T6.11 cell 
does not change the Ca2+ entry induced by 10 µM CCh compared to sicontrol. 
A) T6.11 cells were transfected to 50 nM of β-arrestin 1 and β-arrestin 2 siRNAs and 
sicontrol. β-arrestin 1 and β-arrestin 2 are abbreviated as arrb1 or arrb2 respectively in the 
graph. After 48h of transfection, cells previously loaded with Fura-2-AM were incubated 
for 30 sec in the absence of Ca2+ (in the presence of 0.5 mM EGTA) and were then 
stimulated with 10 µM CCh. Extracellular Ca2+ (1.8 mM) was restored at t=360 sec with 
the presence of CCh stimulation. The blue lined curve represents sicontrol, red lined curve 
represents si β-arrestin 1 and green lined curve represents si β-arrestin 2. B) Net Ca2+ entry 
were calculated by subtracting the [Ca2+]i level at t=360 sec from the maximum [Ca
2+]i 
level recorded once external Ca2+ had been restored. The histogram represents the average 
± S.D. of three independent experiments.  
 
                  
 
A) 
B) 
42 
 
 
 
Figure 12 Specificity of β-arrestin 1 and β-arrestin 2 knockdown in T6.11 cells. 
 
A) T6.11 cells were transfected with 50 nM of control, β-arrestin1 and β-arrestin 2 siRNAs 
and lysed in lysis buffer. 1.5 µg/µl of each protein were loaded onto 10% gel separator 
SDS-PAGE to allow separation. The blocked membranes were then incubated for 16h at 
4ºc in presence of primary antibody of rabbit anti β-arrestin 1 (1/500), mouse anti β-arrestin 
2 (1/1000) diluted in TBST. The membranes were washed three times with TBST and 
incubated for 2 hours at room temperature with antibody HRP conjugated sheep anti-mouse 
IgG or HRP conjugated donkey anti-rabbit IgG. B) The graph below represents the percent 
relative expression of β-arrestin 1 and β-arrestin 2 compare to actin. The blots were scanned 
and quantified by Image J software. These typical experiences are representative of three 
experiments (n=3). 
 
8.3 Involvement of β-arrestin 1 / β-arrestin 2 protein in activation of SOCE and Orai1 
in HEK 293T cells 
 
To investigate the involvement of β-arrestin 1 and β-arrestin 2 in Tg induced SOCE in 
HEK293T cells; we used siRNA specific to β-arrestin 1, β-arrestin 2 that reduces the 
endogenous expression of these proteins by 48% ± 21% and 74.5% ± 14 % respectively 
(Fig. 13A and 13B). siRNA against β-arrestin 1 did not significantly alter the level of 
A) 
B) 
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expression of β-arrestin 2. Similarly, siRNA against β-arrestin 2 did not significantly alter 
the level of expression of β-arrestin 1, indicating the high specificity of these siRNAs 
(fig.14). 
 
HEK293T cells depleted in β-arrestin 1 or β-arrestin 2 were next treated with the fura-2AM 
for 20 min and then intracellular Ca2+ stores were depleted with 1 µM Tg (fig. 14A). As 
shown in fig. 14A, in the absence of extracellular Ca2+, Tg-induced Ca2+ release (t=60 sec) 
resulted in emptying of stored calcium from ER. After Ca2+ level come to basal level (at 
time 360 sec), 1.8 mM CaCl2 added to the external medium in presence of stimulus by 1 
µM Tg. Since the ER is depleted, the Ca2+ entry must almost certainly come from outside 
the cell across the PM.  Intracellular calcium level in β-arrestin 1 knockdown cells was 270 
± 51 nM and 265 ± 61 nM in β-arrestin 2 depleted cells compared to 184 ± 11 nM in 
control cells. In fig.14B, Tg induced Ca2+ entry following the restoration of external Ca2+ 
were significantly increased by 1.5 times for β-arrestin 1 and β-arrestin 2 depleted cells 
compare to that of sicontrol. At this point that this increase Ca2+ entry we observed is 
presumably due to SOCE and that this SOCE is enhanced with KD of the arrestins.  
 
It was proposed that Orai1 is a key regulator for SOCE entry (FESKE 2006) and our results 
shows a significant increase in calcium entry presumably via SOCE.  Determination of 
calcium entry were performed in HEK293T cells depleted with β-arrestin 1, β-arrestin 2, 
Orai1 or Orai1 together with β-arrestin 1 or β-arrestin 2 siRNAs. The cells were transfected 
with 100nM sicontrol, 50nM siOrai1 plus 50nM sicontrol, 50nM si β-arrestin 1 plus 50nM 
siOrai1 or 50nM si β-arrestin 1 plus 50nM of siOrai1. There was no western blot performed 
for Orai1 protein expression since no anti-body was present in the market which can detect 
Orai1 protein. 48h after transfection, cells previously loaded with 1 µM Fura-2-AM were 
incubated for 30 sec in the absence of Ca2+ (in the presence of 0.5 mM EGTA) and were 
then stimulated with 1 µM Tg. Tg stimulation resulted in emptying of stored calcium from 
ER in HEK293T cells. As shown in fig. 15A, [Ca2+]i level reaches 135 nM in sicontrol, 
Orai1, β-arrestin 1, β-arrestin 1 + Orai1 and β-arrestin 2 + Orai1 KD HEK293T cells (fig. 
15A, 15C). After Ca2+ level come to basal level (at time 360 sec), 1.8 mM CaCl2 added to 
the external medium still in presence of Tg stimulation. Since the ER is depleted, the Ca2+ 
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entry must almost certainly come from outside the cell across the PM. As shown in fig.15A 
and 15C, Extracellular Ca2+ (1.8 mM) was restored at t=360 sec with the presence of Tg 
stimulation. An increase Ca2+ entry were observed to 200nM in β-arrestin 1 KD cells 
(fig.15A) and 210nM in β-arrestin 2 KD cells (fig.15C) compared to ~156 ± 35 nM in 
sicontrol cells. However, in double KD β-arrestin 1 – Orai1(fig.15A) or β-arrestin 2 – Orai1 
(fig.15C) cells, [Ca2+]i level is reduced to 94 ± 20 nM and 105 ± 12 nM respectively 
compared to ~156 ± 35 nM in sicontrol. These reduced calcium entry presumably due to 
Orai1 interaction with β-arrestin 1 and β-arrestin 2. In figure 15B and figure 15D, net Ca2+ 
entry were calculated by subtracting the [Ca2+]i level at t=360 sec from the maximum 
[Ca2+]i level recorded once external Ca
2+ had been restored. The histogram represents the 
average ± S.D. of three independent experiments. Activation of Orai1 is enhanced with KD 
of the arrestins. 
 
 
 
Figure 13 The expression of β-arrestin 1 and β-arrestin 2 is greatly reduced by siRNA 
treatment of HEK293T cells 
 
The cells were transfected with 50nM of β-arrestin 1 and β-arrestin 2 siRNAs as described 
in figure 12 and lysed after 48h. 1.5 µg/µl proteins were loaded on SDS-PAGE 10% gel 
separator. The molecular size of reference protein is shown in left. The bar graph below 
represents the % relative expression of β-arrestin 1 and β-arrestin 2 compared to actin.  The 
results are representative of three experiments that gave similar results. The histogram 
represents the average ± SD of three independent experiments. *p < 0.05 
A) 
B) 
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Figure 14 Reduced level of expression of β-arrestin 1 and β-arrestin 2 in HEK293T 
cells increase the Ca2+ entry induced by 1 µM Tg compared to sicontrol. 
 
(A) The β-arrestin 1 and β-arrestin 2 knocked down HEK293T cell increases the Ca2+ entry 
induced by 1 µM Tg. β-arrestin 1 and β-arrestin 2 are abbreviated as arrb1 or arrb2 
respectively in the graph. After 48h of transfection with 50 nM of β-arrestin 1 and β-
arrestin 2 cells were loaded with 1 µM Fura-2-AM and incubated for 30 sec in the absence 
of Ca2+ (in the presence of 0.5 mM EGTA) and were then stimulated with 1 µM Tg for 300 
seconds. Extracellular Ca2+ (1.8 mM) was restored at 360 sec and incubated for 140 sec. 
The graph represents the average of 45 to 65 cells from a typical experiment (n=4). The 
blue lined curve represents sicontrol, red lined curve represents si β-arrestin 1 and green 
lined curve represents si β-arrestin 2. (B) The bar graph represents the average ± SD of 
three independent experiments. The net Ca2+ entry in HEK293T cells induced by Tg-
induced (1 uM) calculated upon subtracting maximum average [Ca2+]i value after restoring 
extracellular calcium (1.8 mM) from [Ca2+]i value before the addition of extracellular value. 
Tg induced Ca2+ entry following the restoration of external Ca2+ were significantly 
increased by 1.5 times for β-arrestin 1 and β-arrestin 2 depleted cells compare to that of 
sicontrol. 
A) 
B) 
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Figure 15 Calcium imaging in HEK293T cells depleted in β-arrestin 1, β-arrestin 2, 
Orai1 or Orai1 together with β-arrestin 1 or β-arrestin 2. 
 
The cells were transfected with 100 nM of sicontrol, 50nM of sicontrol together with 50nM 
of si β-arrestin 1, 50nM of sicontrol together with 50nM of si Orai1, 50nM of si Orai1 
together with 50nM of si β-arrestin 1, 50nM of sicontrol together with 50nM of si β-arrestin 
2 and 50nM of si Orai1 together with 50nM of si β-arrestin 2. A) and C) 48h after 
transfection, cells were loaded with Fura-2-AM as described in figure 14A. Reduced 
expression of β-arrestin 1 and β-arrestin 2 increases the calcium entry. Decreased 
expression of Orai1 in HEK293T cell lower the Ca2+ entry induced by 1 µM Tg. Double 
knock down of β-arrestin 1 – Orai1 or β-arrestin 2 – Orai1 reduces calcium entry into the 
cells compared to control cells. The blue lined curve represents sicontrol, red lined curve 
represents si β-arrestin 1 in figure 15A and  si β-arrestin 2 in figure 15C, green lined curve 
represents si Orai1 and violet lined curved represents si Orai1- si β-arrestin 1 in figure 15A 
and si Orai1 - si β-arrestin 2 in figure 15C. B) D) The graph represents average of 45 to 65 
cells from a typical experiment (n=3) and the average ± SD of three independent 
experiments. Tg-induced (1 uM) net Ca2+ entry in HEK293T cells were also calculated as 
mentioned in figure 14B.  
 
A) 
B) 
C) D) 
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Figure 16 Specificity of β-arrestin 1 and β-arrestin 2 knockdown in HEK293T cells. 
 
A) HEK293T cells were transfected with 50 nM of control, β-arrestin1 and β-arrestin 2 
siRNAs and lysed in lysis buffer. 1.5 µg/µl of protein was loaded onto 10% gel separator 
SDS-PAGE to allow separation. The blocked membranes were then incubated for 16h at 
4ºc in presence of primary antibody of rabbit anti β-arrestin 1 (1/500), mouse anti β-arrestin 
2 (1/1000) diluted in TBST. The membranes were washed three times with TBST and 
incubated for 2 hours at room temperature with antibody HRP conjugated sheep anti-mouse 
IgG or HRP conjugated donkey anti-rabbit IgG. B) The graph below represents the percent 
relative expression of β-arrestin 1 and β-arrestin 2 compare to actin. The blots were scanned 
and quantified by Image J software. These typical experiences are representative of three 
experiments (n=3). 
 
8.4 β-arrestin 1 does not interact with Orai-Myc but interacts with STIM1 in 
HEK293T cells 
 
Given that, in HEK293T cells with double KD β-arrestin 1 – Orai1 and β-arrestin 2 – Orai1 
reduces Ca2+ entry (fig. 15A) and in β-arrestin 1 and β-arrestin 2 KD cells increases Ca2+ 
entry (fig. 15A); we wanted to know if β-arrestin 1 interacts with Orai1 or STIM1 to 
provoke this enhanced calcium entry in β-arrestin 1 depleted cells using a co-
immunoprecipitation assay. HEK293T cells transfected with sicontrol or si β-arrestin 1 
were immunoprecipitated separated by SDS-PAGE and revealed by Werstern immunoblot 
A) 
B) 
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with an anti- β-arrestin 1 antibody, and the presence of STIM1 in the immunoprecipitate 
was revealed by immunoblotting with an anti-STIM1 antibody. STIM1 co-
immunoprecipitated with β-arrestin 1 in control cells (Fig. 17A) but not in β-arrestin 1 
depleted cells (Fig. 17B). β-arrestin 1 band detected on both IP IgG and IP Myc lane (fig. 
17A) and also in β-arrestin 1 depleted cells (fig. 17B) were presumed to be light chain 
antibody. Furthermore, HEK293T cells transfected with cDNA of Orai1 labelled with Myc 
were immunoprecipitated with an anti-Myc antibody. A negative control 
immunoprecipitation with an anti-IgG antibody was also made. None STIM1 and Orai-Myc 
proteins were immunoprecipitated with the negative control, IgG. Proteins were 
immunoprecipitated and separated by SDS-PAGE and revealed by Werstern immunoblot. 
In Figure 17A, we can see the presence of Orai1-Myc at about 35 kDa in the lysate 
transfected with Myc-Orai1. β-arrestin1 depleted cell also immunoprecipitate Orai-Myc at 
about 35 kDa (Fig.17B).  β-arrestin 1 physically interacts with STIM1, and does not 
interacts with Orai1. 
 
 
Figure 17 β-arrestin 1 interacts with STIM1 but not with Orai-Myc 
 
Co-immunoprecipitation of β-arrestin 1 with STIM1 and Orai1. A) The HEK293T cells 
were transfected with sicontrol and cDNA of Orai labelled with Myc. 48 hours after the 
transfection the cells were lysed and immunoprecipitated with anti- β-arrestin 1 (on the 
figure abbreviated as Arrb1), anti-STIM1 and anti-Myc. The presence of the proteins was 
revealed by Werstern blot. B) The HEK293T cells were transfected with si β-arrestin 1 and 
cDNA of Orai labelled with Myc. 48 hour after the transfection the cells were lysed and 
immunoprecipitated with anti- β-arrestin 1 (on the figure abbreviated as Arrb1), anti-
STIM1 and anti-Myc. The presence of the proteins was revealed by Werstern blot.  
 
A) B) 
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8.5 Orai1 localization is not altered in β-arrestin 1 and β-arrestin 2 depleted cells   
 
Previous result shows that β-arrestin 1 does not interacts with Orai1; at that point of time 
we were interested to see the localization of Orai1 in HEK293T cell. Confocal microscopy 
was carried out in HEK293T cells transfected to sicontrol, si β-arrestin 1 and β-arrestin 2. 
The sicontrol, si β-arrestin 1 and β-arrestin 2 cells were transfected with YFP-tagged Orai1. 
The cells were fixed with 3% PFA and permeabilised 0.1% TritonX-100. The fluoresence 
comes from YFP is yellow for Orai1. The Nuclei were stained with Hoechst. In the first 
column (fig. 18 a, d, g), we observe the cell neuclei colored with blue. In the second 
column (fig.18 b, e, h), the Orai1 protein observed mainly at the plasma membrane in 
yellow fluorescent with their YFP tag. The third column represents the superposition of 
first two columns (fig.18 c, f, i). The KD of β-arrestin 1 and β-arrestin 2 were efficient 
using the siRNAs. In HEK293T cells depleted with β-arrestin 1 and β-arrestin 2, no change 
in Orai1 distribution observed compared to sicontrol (Fig 18). 
 
 
Figure 18 Localization of Orai1 in β-arrestin 1 and β-arrestin 2 depleted HEK293 
cells. 
HEK293T cells treated with control siRNA (a-c), β-arrestin 1 siRNA (d-f) and β-arrestin 2 
siRNA (g-i) were transfected with YFP -tagegd orai1. Cells were then fixed in 3 % PFA, 
and permeabilized in 0.1% Triton X-100. The Nuclei were stained with Hoechst. These 
images taken by confocal microscopy represent a single section of 10 µm thickness. 
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8.6  β-arrestin 1 and β-arrestin 2  depletion alter STIM1 intracellular distribution 
 
Since β-arrestin 1 interact with STIM1 and not with Orai1 and that Orai1 localization 
remains unchanged in β-arrestin 1 and β-arrestin 2 KD cells, we were interested to see the 
localization of STIM1 in HEK293T cell. Confocal microscopy was carried out in 
HEK293T cells transfected to sicontrol, si β-arrestin 1 and β-arrestin 2. The sicontrol, si β-
arrestin 1 and β-arrestin 2 cells were transfected with YFP-tagged STIM1. The cells were 
fixed with 3% PFA and permeabilised 0.1% TritonX-100. The fluoresence comes from 
YFP is yellow for STIM1. The Nuclei were stained with Hoechst. In the first column (fig. 
18 a, d, j), we observe the cell neuclei colored with blue. In the second column (fig.18 b, e, 
h, k), the STIM1 protein observed in yellow fluorescent with their YFP tag. The third 
column represents the superposition of first two columns (fig.18 c, f, i, l). The panel a, b, c 
in figure 18 represents HELK293T cells transfected to YFP-tagged STIM1. Panel d,e,f; 
g,h,i and j,k,l represent HEK 293T cells transfected to si control, si β-arrestin 1 and si β-
arrestin 2. The KD of β-arrestin 1 and β-arrestin 2 were efficient using the siRNAs. In 
HEK293T cells depleted with β-arrestin 1 and β-arrestin 2, STIM1 protein distribution were 
presumed to be throughout the plasma membrane as well as in intracellular space compared 
to sicontrol (Fig 19). To better understand the distribution of STIM1 protein, STIM1-YFP 
fluorescent was quantified. Yellow fluorescent for STIM1 in HEK293T cells depleted with 
β-arrestin 1 and β-arrestin 2 as well as in sicontrol were quantified with FLUOVIEW ver.2 
software program. The whole cell was selected to measure the yellow fluorescent and then 
subtracted from the yellow fluorescent observed beneath the membrane, which gives the 
quantity of STIM1-YFP in perimembrane space. Preliminary results for the quantification 
assays shows lower amount of STIM1-YFP intensity in peri-membrane space in β-arrestin 
1 and β-arrestin 2 KD cells compared to sicontrol (Fig. 19B).   
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Figure 19 STIM1-YFP distribution in peri-membrane space is reduced in β-arrestin 1 
and β-arrestin 2 KD cells.  
 
A) HEK293T cells treated with control siRNA (d-f), β-arrestin 1 siRNA (g-i) and β-arrestin 
2 siRNA (j - l) were transfected with YFP -tagegd orai1. Cells were then fixed in 3 % PFA, 
and permeabilized in 0.1% Triton X-100. The Nuclei were stained with Hoechst. These 
images taken by confocal microscopy represent a single section of 10 µm thickness B) The 
whole cell was selected to measure the yellow fluorescent and then subtracted from the 
yellow fluorescent observed beneath the membrane, which gives the quantity for 
perimembrane space. For STIM1-YFP, sicontrol, si β-arrestin 1 and β-arrestin 2; 8, 10, 11 
and 11 individual HEK293T cells were quantified. 
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DISCUSSION 
 
9.1 Role of Rho in calcium signalling and Gα12 / Gα13 in Ca2+ entry through ROCE 
 
Recent studies in our laboratory support a hypothesis that the expression of TRPC6 
channels in the membrane surface can be regulated by RhoA / ROCK pathway 
(FRANCOUER et al., unpublished results). Given that RhoA can be activated by the 
heterotrimeric G proteins Gα12 and Gα13 through the GEF  (WETTSCHURECK N, 2002), 
we evaluated the involvement of Gα12 /Gα13 in activation of ROCE. In our study we have 
seen that, Gα12 / Gα13 are not involved in ROCE. Since the cells were stimulated with the 
AVP that induce Ca2+ release from the sarcoplasmic reticulum and Ca2+ influx via multiple 
Ca2+- permeable non-selective cation channels (THIBONNIER M, 1991) (NEMENOFF 
RA, 1998), we assume that the calcium entry is modulated in Gα12 / Gα13 KD cells. 
Indeed, the AVP at 100nM concentration enables the stimulation of both Ca2+ release and 
Ca2+ influx into the cell (SOBOLOFF J, 2005). This Ca2+ release from the SR is mediated 
through receptor-activated IP3- DAG pathway (THIBONNIER M, 1991) (NEMENOFF 
RA, 1998) and Ca2+ entry is believed to operate through the DAG sensitive receptor 
operated TRPC6 channel in A7r5 cells (DIETRICH A, 2005). Our result shows that 
reduced expression of Gα12 and Gα13 in A7r5 cell have no effect on the [Ca2+]i level after 
AVP stimulation. There is no noticeable difference of [Ca2+]i between the control cells and 
cells with reduced expression of Gα12 and Gα13.  
 
Rho dependent calcium signalling was previously compared between isolated aorta and 
cultured aortic VSMC. In isolated aorta vasopressin stimulated Ca2+ entry was found to be 
influenced by ROCK via myosin phosphorylation (ANNELOES M, 2012) which indicates 
the participation of TRPC channel (HILL AJ, 2006). On the contrary, in aortic cultured 
VSMC, vasopressin-stimulated Ca2+ entry was not affected by ROCK or MLCK inhibition. 
So there could be important differences in the Ca2+ signaling pathways between whole 
artery and cultured cells (ANNELOES M, 2012). Also, it has shown that Gα13 dependent 
MAPK activation is independent of Rho and Rho-kinases, but seems to require Rac/Cdc42 
(BÜCH TR, 2008). The underlying mechanism in this calcium entry pathway was found to 
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be distinct from voltage or store-operated channels in rat aorta and mesenteric artery 
(GHISDAL P, 2003).  We therefore believe that the RhoA / ROCK pathway implicate in 
ROCE (TRPC6) activation but not dependent on Gα12 and Gα13. 
 
9.2 Role of β-arrestin 1/ β-arrestin 2 in intracellular trafficking and involvement in 
calcium entry through ROCE  
 
Given that, Rho / ROCK pathway implicate in ROCE (TRPC6) (FRANCOEUR et al., 
unpublished data) and that RhoA can be regulated by β-arrestins (Ma X, 2012), we also 
evaluated the involvement of β-arrestin 1 and β-arrestin 2 in ROCE. Using calcium imaging 
assay in HEK293 cells stably transfected with TRPC6 (T6.11 cells) cells, we observed an 
increased Tg induced Ca2+ entry through SOCE. Previous studies in βarrestin 1 / β-arrestin 
2 involved uterine contractions were observed due to calcium signalization (GROTEGUT 
CA, 2011). However, the exact pathway or molecular mechanism in the activation of 
calcium signalling is still unknown. In our study, the aim in stimulating T6.11 cells first 
with Tg before stimulating with CCh, is to empty the ER stored Ca2+ that eventually 
activates SOCE channel to calcium entry. Since the cells were stimulated with Tg, a non-
competitive inhibitor of SERCA pump (ROGERS TB, 1995), we assume that Tg releases 
Ca2+ from an intracellular store by a novel mechanism (JACKSON TR, 1988). Tg permits 
the activation of SOCE. Indeed, Tg causes an increase in [Ca2+]i by preventing Ca
2+ to be 
re-pumped into the ER. Soon after the Ca2+ release from ER, Ca2+ leaves the cell by PMCA 
or chelated by EGTA. The [Ca2+]i therefore goes very low and activates PM channels for 
calcium entry. Studies show that, β-arrestin 1 can stimulate the small guanosine 
triphosphatase Ras RhoA and induce stress fiber formation, in conjunction with Gaq/11 
when the AT1AR is activated (BARNES WG, 2005). In hypoxia, RhoA is activated in 
pulmonary artery smooth muscle and endothelial cells. ROCK activation increases Ca2+ 
sensitivity of contraction in vascular smooth muscle cells by phosphorylating the myosin-
binding subunit of myosin light chain phosphatase (MYPT-1) and/or the myosin light chain 
phosphatise inhibitor protein CPI-17 (SOMLYO A P, 2003). However, the exact pathway 
for the calcium entry is still unkown. Taking all these into consideration, we assume that 
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this increased Tg induced Ca2+ entry we observed is contributed to β-arrestin 1 and β-
arrestin 2 and that is due to the activation of SOCE. 
 
 Since Tg stimulation causes the ER to be depleted of Ca2+, we stimulate HEK293 cells 
stably transfected to TRPC6 cell with CCh. β-arrestin 1 and β-arrestin 2  does not seem to 
involve in ROCE. Previous studies with T6.11 cells showed that TRPC6 translocates to the 
PM in the presence of CCh (CAYOUETTE S, 2004) and believed to activate M5 receptor 
preferentially by coupling to the PLC/IP3 pathway through a G protein of the Gq subtype 
(NATHANSON NM, 1987) (CAULFIELD MP, 1993). Hence, the calcium entry that we 
observed upon CCh stimulation was presumed to ROCE (TRPC6). Cells having reduced 
expression of β-arrestin 1 and β-arrestin 2 does not implicate in the changes in calcium 
entry through TRPC6 channel. In that case, we assume that β-arrestin 1 and β-arrestin 2 
does not provoke the activation of ROCE (TRPC6) via RhoA/ROCK pathway. The calcium 
imaging assay was also done without emptying the stored calcium depletion, and the 
stimulation with CCh. There was not any impact on calcium entry via TRPC6 channel in β-
arrestin 1 and β-arrestin 2 KD T6.11 cells.  
 
9.3 β-arrestin1/β-arrestin2 in activation of SOCE (Orai1) 
 
Since we observed an increased the increased calcium entry which we presumed due to 
activation of SOCE and Orai1 being the Ca2+ permeable channel that conducts SOCE  
(FESKE S, 2006) (LI Z, 2007) (PRAKRIYA M, 2006) (VIG M, 2006) (WU MM, 2006) 
(YEROMIN AV, 2006), we hypothesized that this increased calcium entry attribute to 
Orai1. The calcium entry found to be increased in si β-arrestin 1 and si β-arrestin 2 treated 
cells as compared to sicontrol cells which are due to the activation of Orai1. In our study, 
Orai1 KD reduces the calcium entry indicating that Orai1 is important for calcium entry. 
The PM Orai1 channel forms highly Ca2+ selective pores that permit Ca2+ entry. Double 
knockdown of β-arrestin 1- Orai1 or β-arrestin 2 Orai1 indicates the presence of any other 
calcium channel on the PM that contributes to increase calcium. In our study, the [Ca2+]i 
elevation  was almost completely blocked by double KD of β-arrestin 1- Orai1 or β-arrestin 
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2 - Orai1 as compared to  control cells, which support the hypothesis that β-arrestin 1 Orai1 
or β-arrestin 2 Orai1 pathway are involved in the Tg-induced [Ca2+]i entry.  
 
9.4 Orai1 does not localize with β-arrestin 1/ β-arrestin 2 
 
Experiment carried to see localization of β-arrestin 1/Orai1 or β-arrestin 2/Orai1 using 
confocal microscopy. We showed that β-arrestin 1 or β-arrestin 2 does not impact on the 
Orai1 distribution. Indeed, the elevated calcium entry does not alter the Orai1 distribution. 
In our study we observed, in HEK293T cells with reduced expression of β-arrestin 1 or β-
arrestin 2, Orai1 was distributed mostly at the cell periphery, as observed in control cells. 
However, it is clear from our results that β-arrestins play significant role in Orai1 
activation. What could trigger this enhance calcium entry remains unclear. This could be 
due to the implication of β-arrestins as signalosome that can be through the recruitment of 
other signaling proteins by β-arrestins to the receptor in controlling several cellular 
functions (DEWIRE SM, 2007). Therefore, there could be an intermediate protein, 
presumably, which can be recruited by β-arrestins in the activation of Orai1. 
 
9.5 β-arrestin 1 interacts with STIM1 in HEK293T cells 
 
Using a CoIP assay we indeed found an interaction between β-arrestin 1 and STIM1, while 
no interaction was observed between β-arrestin 1 and Orai1 in HEK293T cell .Our result 
indicate that, the increase in calcium entry was due to the interaction between β-arrestin 1 
and STIM1 not to Orai1. However, Orai1 along with STIM1 have been identified as the 
key components of CRAC channel function (CAHALAN MD, 2009)  (LIOU J, 2005) 
(MERCER C, 2006) (PEINELT C, 2006) (ROOS J, 2005). STIM1-Orai1 interactions at the 
ER- PM junctions interact via CAD/SOAR region of STIM1 which couples strongly and 
interact directly with the Orai1 C-terminus (PARK CY, 2009) (DERLER I, 2013) and to a 
weaker extent to Orai1 N-terminus (DERLER I, 2013). There is also evidence of STIM–
Orai interaction at other sites like ER-secretory granule junctions (DICKSON EJ, 2012), 
ER-phagosome junctions (NUNES P, 2012), and ER-plasma membrane contact where 
sarcoplasmic reticulum is present nearer to transverse tubule in skeletal muscle. Hence, in 
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activation of the Orai1 channel upon β-arrestin 1 / β-arrestin 2 KD in HEK293T cells could 
involve STIM1 that gets involved. Studies show that, the loss of Ca2+ from ER triggers the 
oligomerization of STIM1 (LIOU J, 2007) (STATHOPULOS PB, 2006) and accumulates 
in regions of the ER located within 10–25 nm of the PM (WU MM, 2006). Cytosolic CAD 
region of STIM1 is a potent activator of Orai1 channels. The group of PARK CY et al., 
evaluated the intracellular localization of CAD and Orai1. In the absence of Orai1, YFP-
CAD was localized diffusely throughout the cytoplasm, but the introduction of Orai1 led to 
a dramatic recruitment of YFP-CAD to the PM. This result suggests the formation of these 
two proteins. We believe that β-arrestins can modulate this STIM1-Orai1 pathway. 
Therefore, we proposed a hypothesized model in which β-arrestin 1, as an intermediate 
molecule, could bridge the gap between STIM1 and Orai1 (fig.20). Indeed, it is possible 
that β-arrestins could oligomerize to link the STIM1-Orai1 proteins or could bind to CAD 
region of STIM1 protein in activation of Orai1. To date, the functional domains of β-
arrestins are not yet well known. We think it would be interesting to determine β-arrestins 
binding domains with STIM1. We also assume that, the implication of β-arrestins in SOCE 
activation is independent of RhoA/ROCK pathway . 
 
Figure 20 Hypothesized model on regulation of β-arrestin 1 / β-arrestin 2 in SOCE 
activation. 
 
STIM1 in an extended conformation, bridging the distance from ER to plasma membrane. 
Taken from (HOGAN PG, 2015). A single STIM monomer is shown in red, but the active 
extended form in cells is oligomeric. The calcium-sensing EF-SAM domain of STIM1 in 
the ER lumen, the cytoplasmic CC1 region that both stabilizes inactive STIM and transmits 
the activating conformational change upon ER calcium store depletion, the SOAR/CAD 
domain that recruits and gates Orai channels, and the polybasic tail that interacts with 
plasma membrane phosphoinositides. (1) is the possible pathway to control SOCE. 
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CONCLUSION 
 
Calcium acts as a signal transduction molecule. When calcium enters into the cell, it exerts 
cellular functions in response to stimulation.  My master project reveals that, β-arrestin 1 
and β-arrestin 2 are involved in controlling store-operated calcium entry and control the 
quantity of STIM1 in the endoplasmic reticulum. This is important since a lack of such 
control would lead to calcium overloading and its associated pathological effects. We have 
demonstrated that Gα12 /Gα13 or β-arrestin 1 / β-arrestin 2 does not impact the activation 
of ROCE. Instead, SOCE channel was shown to be activated in both HEK293T and 
HEK293 cells stably transfected to TRPC6 cells depleted with β-arrestin 1 / β-arrestin 2. 
Our results showed that, Orai1 is not involved in increased calcium entry in β-arrestin 1 / β-
arrestin 2 KD cells.  Orai1 distribution at plasma membrane remains unchanged in β-
arrestin 1 or β-arrestin 2 KD cells. We have also demonstrated that, β-arrestin 1 interacts 
with STIM1 protein. The interaction between β-arrestin 1 and STIM1 seems to occur at the 
intracellular region. possibly in SOAR/CAD region.  
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PERSPECTIVE 
 
To further confirm the interaction between β-arrestin 1 / β-arrestin 2 and STIM1; BRET 
technology could be used. This technology has been previously used to detect ligand-
induced translocation of β-arrestins to GPCR C-terminal tails of GPCRs (FERGUSON SS, 
2004). Variations in the BRET signal can be monitored kinetically or in concentration 
dependent manner after ligand binding. Changes in BRET signal can increase or decrease 
in the number and/or rate of interactions between the β-arrestins and STIM1 proteins after 
stimulating with thapsigargin. The BRET signals can also change due to conformational 
changes of β-arrestins and STIM1 protein. 
 
Experiments carried out using confocal microscopy give us some interesting observation on 
STIM1 redistribution upon KD of β-arrestin 1 / β-arrestin 2.  The very preliminary results 
for the quantification of STIM1 showed a lower amount of STIM1-YFP intensity in peri-
membrane space in β-arrestin 1 / β-arrestin 2 KD cells. This indicates a better control of 
STIM1 distribution at the ER region in β-arrestin 1 / β-arrestin 2 KD cells. Moreover, 
quantification of STIM1 at ER can be ensured by performing (n=3) confocal microscopy to 
get reproducible result.   
 
Most importantly, to better define role of β-arrestin 1 and β-arrestin 2 in calcium signalling 
pathways via SOCE, mouse embryonic fibroblast cells (MEF) isolated from β-arrestins 1 
and 2 double knockout embryos can be used . Calcium imaging with the double knock out 
β-arrestin 1 and β-arrestin 2 in MEF cells would modulate the calcium entry. It would be 
interesting to see in which pattern β-arrestins are connected to STIM1 and Orai1, what are 
the binding domains of β-arrestins that involve in the interaction with STIM1. Even though, 
we do not have clear evidence of interaction of β-arrestin 2 protein with STIM1. Hence, it 
would also be interesting to see the interaction between β-arrestin 2 and STIM1 protein. It 
would be appropriate to check the level of expression β-arrestin 2 in β-arrestin 1 KD cells 
and vice versa, that could lead to interaction of β-arrestin 2 or β-arrestin 1 protein with 
STIM1 and calcium signalization. Finally we proposed a model in which β-arrestins could 
interact with CAD/SOAR domain of STIM1 at the ER and that could somehow hinders the 
activation of Orai1.  
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